<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Research Foundation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2011.00039</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Review Article</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Glutathione <italic>S</italic>-Transferases in Pediatric Cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Luo</surname> <given-names>Wen</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<!-- http://www.frontiersin.org/Community/WhosWhoDetails.aspx?UID=39822&d=1&sname=WenLuo_1&name=Science -->
</contrib>
<contrib contrib-type="author">
<name><surname>Kinsey</surname> <given-names>Michelle</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Schiffman</surname> <given-names>Joshua D.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<!-- http://www.frontiersin.org/Community/WhosWhoDetails.aspx?UID=32458&d=2&sname=JoshuaSchiffman&name=Medicine -->
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Lessnick</surname> <given-names>Stephen L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn001">&#x0002A;</xref>
<!-- http://www.frontiersin.org/Community/WhosWhoDetails.aspx?UID=32422&d=2&sname=StephenLessnick&name=Medicine -->
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>The Department of Oncological Sciences, University of Utah School of Medicine</institution> <country>Salt Lake City, UT, USA</country></aff>
<aff id="aff2"><sup>2</sup><institution>The Center for Children&#x02019;s Cancer Research, Huntsman Cancer Institute, University of Utah</institution> <country>Salt Lake City, UT, USA</country></aff>
<aff id="aff3"><sup>3</sup><institution>The Division of Pediatric Hematology/Oncology, University of Utah School of Medicine</institution> <country>Salt Lake City, UT, USA</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Mignon Lee-Cheun Loh, University of California, USA</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Martin Stanulla, University Hospital Schleswig-Holstein, Germany; Kenneth Tew, Medical University of South Carolina, USA</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Stephen L. Lessnick, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, USA. e-mail: <email>stephen.lessnick&#x00040;hci.utah.edu</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Frontiers in Pediatric Oncology, a specialty of Frontiers in Oncology.</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>10</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="collection">
<year>2011</year>
</pub-date>
<volume>1</volume>
<elocation-id>39</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>07</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>10</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2011 Luo, Kinsey, Schiffman and Lessnick.</copyright-statement>
<copyright-year>2011</copyright-year>
<license license-type="open-access" xlink:href="http://www.frontiersin.org/licenseagreement"><p>This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.</p></license>
</permissions>
<abstract>
<p>The glutathione <italic>S</italic>-transferases (GSTs) are a family of ubiquitously expressed polymorphic enzymes important for detoxifying endogenous and exogenous compounds. In addition to their classic activity of detoxification by conjugation of compounds with glutathione, many other functions are now found to be associated with GSTs. The associations between GST polymorphisms/functions and human disease susceptibility or treatment outcome, mostly in adults, have been extensively studied and reviewed. This mini review focuses on studies related to GST epidemiology and functions related to pediatric cancer. Opportunities to exploit GST in pediatric cancer therapy are also discussed.</p>
</abstract>
<kwd-group>
<kwd>glutathione <italic>S</italic>-transferase</kwd>
<kwd>pediatric cancer</kwd>
<kwd>epidemiology</kwd>
<kwd>drug resistance</kwd>
<kwd>therapeutic target</kwd>
<kwd>microsatellite</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="112"/>
<page-count count="11"/>
<word-count count="8496"/>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>General Information on Glutathione <italic>S</italic>-Transferases</title>
<sec>
<title>The GST family</title>
<p>Glutathione <italic>S</italic>-transferase (GST) isozymes were originally discovered in rat liver cytosol during the early 1960s (Booth et al., <xref ref-type="bibr" rid="B16">1961</xref>; Coombes and Stakelum, <xref ref-type="bibr" rid="B20">1961</xref>). GSTs are drug-metabolizing enzymes that catalyze conjugation of glutathione with carcinogens, drugs, toxins, or products of oxidative stress. Two distinct superfamilies of GST isozymes exist (Table <xref ref-type="table" rid="T1">1</xref>). One superfamily comprises cytosolic, soluble, dimeric enzymes. At present, eight distinct classes have been identified in this superfamily: alpha, kappa, mu, omega, pi, sigma, theta, and zeta. The other superfamily is composed of microsomal, membrane bound, trimeric proteins. This family of proteins is also called MAPEG (membrane-associated proteins in eicosanoid and glutathione metabolism; Hayes and Strange, <xref ref-type="bibr" rid="B37">2000</xref>). While GSTs are expressed in all tissues, specific isozyme distribution across different tissues in mammals is variable and complex (Hiley et al., <xref ref-type="bibr" rid="B39">1989</xref>; Strange et al., <xref ref-type="bibr" rid="B92">1989</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Human GSTs and their biochemical properties</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Super-family</th>
<th align="left" valign="top">Class</th>
<th align="left" valign="top">Chromosome</th>
<th align="left" valign="top">Gene</th>
<th align="left" valign="top">Protein</th>
<th align="left" valign="top">Substrate</th>
<th align="left" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Cytosolic</td>
<td align="left" valign="top">Alpha</td>
<td align="left" valign="top">6p12.2</td>
<td align="left" valign="top"><italic>GSTA 1</italic></td>
<td align="left" valign="top">GSTA1-1</td>
<td align="left" valign="top">CDNB, NBD-Cl, D5AD, PGE2, cholesterol a-oxide, dibenzo(a,l)pyrene</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Dreij et al. (<xref ref-type="bibr" rid="B27">2002</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTA 2</italic></td>
<td align="left" valign="top">GSTA2-2</td>
<td align="left" valign="top">CDNB, NBD-Cl, CuOOH, PGD2</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTA 3</italic></td>
<td align="left" valign="top">GSTA3-3</td>
<td align="left" valign="top">&#x00394;5AD, dibenzo(a,l)pyrene</td>
<td align="left" valign="top">Johansson and Mannervik (<xref ref-type="bibr" rid="B51">2001</xref>), Dreij et al. (<xref ref-type="bibr" rid="B27">2002</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTA 4</italic></td>
<td align="left" valign="top">GSTA4-4</td>
<td align="left" valign="top">HNE, ETA</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Hubatsch et al. (<xref ref-type="bibr" rid="B47">1998</xref>), Balogh et al. (<xref ref-type="bibr" rid="B8">2011</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cytosolic</td>
<td align="left" valign="top">Mu</td>
<td align="left" valign="top">1p13.3</td>
<td align="left" valign="top"><italic>GSTM1</italic></td>
<td align="left" valign="top">GSTM1-1</td>
<td align="left" valign="top">CDNB, AFB1-epoxide, trans-4-phenyl-3-buten-2-one, tSO, adrenochrome, aflatoxin B1-8,9-epoxide</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Baez et al. (<xref ref-type="bibr" rid="B7">1997</xref>), Johnson et al. (<xref ref-type="bibr" rid="B53">1997</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTM2</italic></td>
<td align="left" valign="top">GSTM2-2</td>
<td align="left" valign="top">CDNB, DCNB, cyano DMNG, aminochrome, dopachrome, noradrenochrome</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Baez et al. (<xref ref-type="bibr" rid="B7">1997</xref>), Norrgard and Mannervik (<xref ref-type="bibr" rid="B72">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTM3</italic></td>
<td align="left" valign="top">GSTM3-3</td>
<td align="left" valign="top">H2O2, PGH2</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Beuckmann et al. (<xref ref-type="bibr" rid="B12">2000</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTM4</italic></td>
<td align="left" valign="top">GSTM4-4</td>
<td align="left" valign="top">n.d.</td>
<td align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTM5</italic></td>
<td align="left" valign="top">GSTM5-5</td>
<td align="left" valign="top">n.d.</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Cytosolic</td>
<td align="left" valign="top">Pi</td>
<td align="left" valign="top">11q13</td>
<td align="left" valign="top"><italic>GSTP1</italic></td>
<td align="left" valign="top">GSTP1-1</td>
<td align="left" valign="top">CDNB, acrolein, adenine propenal, thymine propenal, ETA, 4-vinylpyridine, BPDE, benzo(c)-phenanthrene, benzo(g)chrysene, BITC, actin, GSTP, peroxiredoxin VI</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Berhane et al. (<xref ref-type="bibr" rid="B11">1994</xref>), Coles et al. (<xref ref-type="bibr" rid="B19">2000</xref>), Hu et al. (<xref ref-type="bibr" rid="B41">1997a</xref>,<xref ref-type="bibr" rid="B42">b</xref>,<xref ref-type="bibr" rid="B43">c</xref>), Hu et al. (<xref ref-type="bibr" rid="B44">1998</xref>), Nakamura et al. (<xref ref-type="bibr" rid="B71">2000</xref>), Tew et al. (<xref ref-type="bibr" rid="B97">2011</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cytosolic</td>
<td align="left" valign="top">Sigma</td>
<td align="left" valign="top">4q22.3</td>
<td align="left" valign="top"><italic>GSTS1</italic></td>
<td align="left" valign="top">GSTS1-1</td>
<td align="left" valign="top">PGH2</td>
<td align="left" valign="top">Kanaoka et al. (<xref ref-type="bibr" rid="B56">1997</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cytosolic</td>
<td align="left" valign="top">Theta</td>
<td align="left" valign="top">22q11.2</td>
<td align="left" valign="top"><italic>GSTT1</italic></td>
<td align="left" valign="top">GSTT1-1</td>
<td align="left" valign="top">NBD-Cl, CuOOH, acrylamide, glycidamide, EO, CAA, DCM, DBE, EPNP, MB</td>
<td align="left" valign="top">Huang et al. (<xref ref-type="bibr" rid="B45">1997</xref>), Sherratt et al. (<xref ref-type="bibr" rid="B89">1997</xref>) Sherratt et al. (<xref ref-type="bibr" rid="B89">1997</xref>), Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Doroshyenko et al. (<xref ref-type="bibr" rid="B26">2009</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT2</italic></td>
<td align="left" valign="top">GSTT2-2</td>
<td align="left" valign="top">CuOOH, 1-menaphthyl sulfate</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Tan et al. (<xref ref-type="bibr" rid="B94">1996</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cytosolic</td>
<td align="left" valign="top">Zeta</td>
<td align="left" valign="top">14q24.3</td>
<td align="left" valign="top"><italic>GSTZ1</italic></td>
<td align="left" valign="top">GSTZ1-1</td>
<td align="left" valign="top">DCA, fluoroacetate, maleylacetoacetate</td>
<td align="left" valign="top">Tong et al. (<xref ref-type="bibr" rid="B101">1998a</xref>,<xref ref-type="bibr" rid="B102">b</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cytosolic</td>
<td align="left" valign="top">Omega</td>
<td align="left" valign="top">10q24.3</td>
<td align="left" valign="top"><italic>GSTO1</italic></td>
<td align="left" valign="top">GSTO1-1</td>
<td align="left" valign="top">MMA, dehydroascorbate, HED, <italic>s</italic>-(4-nitrophenacyl)glutathione</td>
<td align="left" valign="top">Tanaka-Kagawa et al. (<xref ref-type="bibr" rid="B95">2003</xref>), Board et al. (<xref ref-type="bibr" rid="B14">2000</xref>, <xref ref-type="bibr" rid="B13">2008</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Mitochondria bound</td>
<td align="left" valign="top">Kappa</td>
<td align="left" valign="top">7q34-35</td>
<td align="left" valign="top"><italic>GSTK1</italic></td>
<td align="left" valign="top">GSTK1-1</td>
<td align="left" valign="top">2-Hydroxychromene-2-carboxylate</td>
<td align="left" valign="top">Robinson et al. (<xref ref-type="bibr" rid="B79">2004</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Micro-somal</td>
<td align="left" valign="top">MAPEG</td>
<td align="left" valign="top">12p12.3</td>
<td align="left" valign="top"><italic>MGST1</italic></td>
<td align="left" valign="top">MGST1</td>
<td align="left" valign="top">CDNB, NBD-Cl, 4-nitrobenzyl chloride, Couth</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">4q28.3</td>
<td align="left" valign="top"><italic>MGST2</italic></td>
<td align="left" valign="top">MGST2</td>
<td align="left" valign="top">CDNB, 5-HPETE, LTA4</td>
<td align="left" valign="top">Hayes and McLellan (<xref ref-type="bibr" rid="B36">1999</xref>), Jakobsson et al. (<xref ref-type="bibr" rid="B48">1996</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">1q23</td>
<td align="left" valign="top"><italic>MGST3</italic></td>
<td align="left" valign="top">MGST3</td>
<td align="left" valign="top">5-HPETE, LTA4</td>
<td align="left" valign="top">Jakobsson et al. (<xref ref-type="bibr" rid="B49">1997</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">5</td>
<td align="left" valign="top"><italic>LTC4S</italic></td>
<td align="left" valign="top">LTC4S</td>
<td align="left" valign="top">LTA4</td>
<td align="left" valign="top">Jakobsson et al. (<xref ref-type="bibr" rid="B48">1996</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">13q12</td>
<td align="left" valign="top"><italic>FLAP</italic></td>
<td align="left" valign="top">FLAP</td>
<td align="left" valign="top">Binds to AA and MK-886</td>
<td align="left" valign="top">Mancini et al. (<xref ref-type="bibr" rid="B62">1993</xref>), Mancini et al. (<xref ref-type="bibr" rid="B63">2001</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Modified from Hayes and Strange (<xref ref-type="bibr" rid="B37">2000</xref>). 5-HPETE, 5-hydroperoxyeicosatetraenoic acid; AA, arachidonic acid; BPDE, benzo(a)pyrene diolepoxide; BITC, benzyl isothiocyanate; CAA, chloroacetaldehyde; CDNB, 1-chloro-2,4-dinitrobenzene; CuOOH, cumene hydro-peroxide; DBE, dibromoethane; DCA, dichloroacetic acid; DCM, dichloromethane; DCNB, 1,2-dichloro-4-nitrobenzene; ?5AD, delta(5)-androstene-3,17(20)-dione; EO, ethylene oxide; EPNP, 1,2-epoxy-3-(<italic>p</italic>-nitrophenoxy)propane; ETA, ethacrynic acid; HED, hydroxyethyl disulfide; HNE, 4-hydroxynonenal; LTA4, leukotriene A4; MB, methyl bromide; MMA, mono-methylarsonic acid; n.d., not determined; tSO, trans-stilbene oxide</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>GST substrates</title>
<p>Crystal structures have been determined for many soluble GSTs, often with bound substrates or products (Oakley, <xref ref-type="bibr" rid="B73">2011</xref>). The &#x0201C;canonical fold&#x0201D; of a soluble GST subunit reveals an N-terminal &#x003B1;/&#x003B2; domain forming the GSH-binding site (G-site) and a second, &#x003B1;-helical domain forming most of the H-site that binds the electrophilic substrate (Figure <xref ref-type="fig" rid="F1">1</xref>). CDNB (1-chloro-2,4-dinitrobenzene) was initially adopted by biochemists as a &#x0201C;universal&#x0201D; GST substrate. However, it was soon realized that, although different transferases may exhibit overlapping substrate specificities, no common substrate exists that is metabolized by all GST isozymes (Table <xref ref-type="table" rid="T1">1</xref>). Different amino acids in the substrate-binding site (H-site) of GST isozymes can account for substrate specificities. In view of the separate evolutionary histories of the cytosolic and MAPEG superfamilies, it is not surprising that they display marked differences in catalytic activities (Armstrong, <xref ref-type="bibr" rid="B4">1997</xref>). Because its binding pocket for electrophiles is hydrophobic, Microsomal GST1 (MGST1) is uniquely suited among the GSTs to detoxify reactive intermediates of a more hydrophobic nature (Schaffert, <xref ref-type="bibr" rid="B85">2011</xref>). The substrate specificity of individual GST isozymes suggests that each of them play a unique role in biotransformation of drugs. Genetic variations in these enzymes will therefore influence the response of individuals to environmental agents.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>A cartoon diagram of GSTP, a representative of a soluble GST enzyme</bold>. The N-terminal GSH-binding site (G-site, in yellow) and the C-terminal H-site (in purple) that binds the electrophilic substrate (in orange) are shown.</p></caption>
<graphic xlink:href="fonc-01-00039-g001.tif"/>
</fig>
</sec>
<sec>
<title>Polymorphism and epidemiology</title>
<p>Genetic polymorphisms in the <italic>GST</italic> genes arise from nucleotide alterations that may change codons to generate unique alleles or even null genotypes. These amino acid substitutions cause steric changes in the substrate-binding site of the enzyme. As a consequence, the enzymatic activities of GST are significantly affected. Because different GST proteins differ in their ability to catalyze specific detoxification reactions, polymorphisms in <italic>GST</italic> will likely impact response to specific therapies. Many molecular epidemiological studies have tested associations between polymorphisms of <italic>GST</italic> genes and disease susceptibility. The results of such studies have often been conflicting. As a consequence, a number of meta-analyses have been carried out as part of the Human Genome Epidemiology (HuGE) Network, which provided evidence that <italic>GST</italic> polymorphisms can result in a small but significant increase in risk of some types of cancers or diseases (Hayes and Strange, <xref ref-type="bibr" rid="B37">2000</xref>; Bolt and Their, <xref ref-type="bibr" rid="B15">2006</xref>; Di Pietro et al., <xref ref-type="bibr" rid="B24">2010</xref>; Economopoulos and Sergentanis, <xref ref-type="bibr" rid="B29">2010</xref>; Josephy, <xref ref-type="bibr" rid="B55">2010</xref>; McMahon et al., <xref ref-type="bibr" rid="B65">2010</xref>). However, most meta-analyses suffered from a serious limitation: fail to distinguish between heterozygous and homozygous genotypes, which resulted in heterogeneity between studies. Now boundaries of the deletion polymorphisms have been cloned and analytical methods that assess copy number such as real-time PCR are now available (Timofeeva et al., <xref ref-type="bibr" rid="B99">2009</xref>). These will be helpful in dissolving some of the heterogeneity observed in clinical evaluations.</p>
</sec>
<sec>
<title>Functions of GST</title>
<p>The classic activity of the GSTs is to detoxify reactive electrophiles by conjugation to glutathione (GSH), thereby reducing the likelihood of deleterious interactions between such reactive species and essential cellular components like proteins and nucleic acids. Knockout and transgenic mouse models were generated for many GST family members which helped to reveal the physiological function of GST isozymes (Elsby et al., <xref ref-type="bibr" rid="B30">2003</xref>; Henderson and Wolf, <xref ref-type="bibr" rid="B38">2011</xref>). Based on these and other model systems, many other activities are now associated with GSTs, including regulation of signaling pathways and anti-apoptotic activity by GSTP (Tew et al., <xref ref-type="bibr" rid="B97">2011</xref>), anti- and pro-inflammatory functions of sigma-class GSTs (Flanagan and Smythe, <xref ref-type="bibr" rid="B31">2011</xref>), activities of MGST1 related to mitochondria (Aniya and Imaizumi, <xref ref-type="bibr" rid="B3">2011</xref>), regulation of the cardiac muscle ryanodine receptor (Dulhunty et al., <xref ref-type="bibr" rid="B28">2011</xref>), and functions associated with asthma (Minelli et al., <xref ref-type="bibr" rid="B68">2010</xref>).</p>
<sec>
<title>GSTs and signaling pathway regulation</title>
<p>It is becoming apparent that GSTP family members participate in the maintenance of cellular redox homeostasis through a variety of mechanisms (Tew et al., <xref ref-type="bibr" rid="B97">2011</xref>). GSTP1, for example, displays an anti-apoptotic activity based on protein&#x02013;protein interactions with c-Jun N-terminal kinase (JNK; Adler et al., <xref ref-type="bibr" rid="B1">1999</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>). GSTP1 was implicated in mediating <italic>S</italic>-glutathionylation of specific clusters of target proteins and in reactions that play a negative regulatory role in some kinase pathways through other protein&#x02013;protein interactions. GSTP1 has also been implicated in regulating tumor necrosis factor-alpha (TNF-alpha) signaling primarily through a physical association with tumor necrosis factor receptor-associated factor 2 (TRAF2; Wu et al., <xref ref-type="bibr" rid="B108">2006</xref>). In addition, physical interactions between the HPV16 E7 viral factor and GSTP1 were found to improve survival capabilities of host cells (Mileo et al., <xref ref-type="bibr" rid="B67">2009</xref>). GSTA1 is also capable of suppressing JNK signaling caused by inflammatory cytokines or oxidative stress, likely because of the homology between GST A and P family members, (Romero et al., <xref ref-type="bibr" rid="B80">2006</xref>). It was also reported that GSTM1 binds and inhibits the activity of Apoptosis Signaling Kinase-1 (ASK1; Cho et al., <xref ref-type="bibr" rid="B18">2001</xref>). The GSTM1:ASK1 interaction dissociates under oxidative stress or heat shock, leading to activation of ASK1 and apoptosis (Dorion et al., <xref ref-type="bibr" rid="B25">2002</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Cartoon model of how GSTP1&#x02013;JNK and GSTP1&#x02013;TRAF2 interactions modulate JNK and TNF-&#x003B1; signaling pathways</bold>. In non-stressed cells, GSTP1 form complexes with JNK and TRAF2 respectively. GSTP1&#x02013;JNK interaction keeps JNK at low activity, while GSTP1&#x02013;TRAF2 interaction competes against TRAF2&#x02013;ASK1 binding which also leads to low JNK activity. In cells exposed to ROS or TNF-&#x003B1;, GSTP1 dissociates from the complexes and accumulates as oligomers, with resultant activation of JNK and downstream signaling pathways.</p></caption>
<graphic xlink:href="fonc-01-00039-g002.tif"/>
</fig>
</sec>
<sec>
<title>MGST1 and its dual function in mitochondria</title>
<p>Microsomal GST1 protects cells (and mitochondria) from oxidative stress by both conjugation and glutathione peroxidase functions (Johansson et al., <xref ref-type="bibr" rid="B52">2010</xref>; Aniya and Imaizumi, <xref ref-type="bibr" rid="B3">2011</xref>; Schaffert, <xref ref-type="bibr" rid="B85">2011</xref>). MCF7 cells overexpressing MGST1 showed protection against agents that induce peroxidation. Mitochondria in these cells were shown to be protected from oxidative insult as measured by calcium loading capacity and respiration. MGST1 also induced cellular resistance against cisplatin in these cells (Johansson et al., <xref ref-type="bibr" rid="B52">2010</xref>). In addition to these protective effects, MGST1 also has deleterious effects that contribute to oxidative stress-induced liver injury. Preliminary studies indicated that mitochondrial MGST1 was activated by reactive oxygen species (ROS). This activation led to its aggregation and induction of non-classical mitochondrial permeability transition (MPT). MPT induces mitochondrial dysfunction which results in apoptosis and necrosis. Therefore, depending on the context, MGST1 activation can either exhibit a protective or toxic effect on the liver and possibly other tissues (Schaffert, <xref ref-type="bibr" rid="B85">2011</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p><bold>Case&#x02013;control studies on association of GST polymorphism with susceptibility or risk of relapse of childhood cancers</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Reference</th>
<th align="left" valign="top">Tumor type</th>
<th align="left" valign="top">Population</th>
<th align="left" valign="top">Region</th>
<th align="left" valign="top">Age (year; Median)</th>
<th align="left" valign="top">Genotype</th>
<th align="left" valign="top">No. of cases</th>
<th align="left" valign="top">No. of controls</th>
<th align="left" valign="top">Odds ratio</th>
<th align="left" valign="top">95% Confidence interval</th>
<th align="left" valign="top"><italic>p</italic> Value</th>
<th align="left" valign="top">Treatment applied</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="12" align="left"><bold>SUSCEPTIBILITY</bold></td>
</tr>
<tr>
<td align="left" valign="top">Krajinovic et al. (<xref ref-type="bibr" rid="B59">1999</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">French Canadian</td>
<td align="left" valign="top">Canada</td>
<td align="left" valign="top">1&#x02013;21 (8)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">174</td>
<td align="left" valign="top">304</td>
<td align="left" valign="top">1.8</td>
<td align="left" valign="top">1.2&#x02013;2.6</td>
<td align="left" valign="top">0.004</td>
<td align="left" valign="top">NA</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">176</td>
<td align="left" valign="top">274</td>
<td align="left" valign="top">0.9</td>
<td align="left" valign="top">0.5&#x02013;1.5</td>
<td align="left" valign="top">0.8</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Pakakasama et al. (<xref ref-type="bibr" rid="B75">2005</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">Thai</td>
<td align="left" valign="top">Thailand</td>
<td align="left" valign="top">0.83&#x02013;14.75(6.25)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">107</td>
<td align="left" valign="top">320</td>
<td align="left" valign="top">1.7</td>
<td align="left" valign="top">1.0&#x02013;2.7</td>
<td align="left" valign="top">0.04</td>
<td align="left" valign="top">NA</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">107</td>
<td align="left" valign="top">320</td>
<td align="left" valign="top">1.4</td>
<td align="left" valign="top">0.9&#x02013;2.2</td>
<td align="left" valign="top">0.12</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTM1</italic> and <italic>GSTTT1</italic> null</td>
<td align="left" valign="top">107</td>
<td align="left" valign="top">320</td>
<td align="left" valign="top">1.7</td>
<td align="left" valign="top">1.1&#x02013;2.9</td>
<td align="left" valign="top">0.02</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Joseph et al. (<xref ref-type="bibr" rid="B54">2004</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">Indian</td>
<td align="left" valign="top">India</td>
<td align="left" valign="top">0&#x02013;14 (NA)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">118</td>
<td align="left" valign="top">118</td>
<td align="left" valign="top">2.1</td>
<td align="left" valign="top">1.21&#x02013;3.67</td>
<td align="left" valign="top">0.009</td>
<td align="left" valign="top">NA</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">118</td>
<td align="left" valign="top">118</td>
<td align="left" valign="top">1.82</td>
<td align="left" valign="top">0.8&#x02013;4.16</td>
<td align="left" valign="top">0.16</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Ashton et al. (<xref ref-type="bibr" rid="B5">2007</xref>)</td>
<td align="left" valign="top">NB</td>
<td align="left" valign="top">White</td>
<td align="left" valign="top">Australia</td>
<td align="left" valign="top">0&#x02013;13.51 (1.26)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">89</td>
<td align="left" valign="top">116</td>
<td align="left" valign="top">1.6</td>
<td align="left" valign="top">1.02&#x02013;2.49</td>
<td align="left" valign="top">0.04</td>
<td align="left" valign="top">Standard protocol (see Reference)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">New Zealand</td>
<td colspan="1" align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">88</td>
<td align="left" valign="top">117</td>
<td align="left" valign="top">0.67</td>
<td align="left" valign="top">0.37&#x02013;1.21</td>
<td align="left" valign="top">0.185</td>
</tr>
<tr>
<td colspan="1" align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTP1</italic> V105 homozygote</td>
<td align="left" valign="top">88</td>
<td align="left" valign="top">203</td>
<td align="left" valign="top">1.16</td>
<td align="left" valign="top">0.64&#x02013;2.13</td>
<td align="left" valign="top">0.620</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Davies et al. (<xref ref-type="bibr" rid="B22">2000</xref>)</td>
<td align="left" valign="top">AML/MDS</td>
<td align="left" valign="top">White</td>
<td align="left" valign="top">U.S.</td>
<td align="left" valign="top">NA (NA)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">232</td>
<td align="left" valign="top">153</td>
<td align="left" valign="top">2.0</td>
<td align="left" valign="top">1.3&#x02013;3.1</td>
<td align="left" valign="top">0.001</td>
<td align="left" valign="top">NA</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">232</td>
<td align="left" valign="top">153</td>
<td align="left" valign="top">1.6</td>
<td align="left" valign="top">0.9&#x02013;2.9</td>
<td align="left" valign="top">0.12</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Krajinovic et al. (<xref ref-type="bibr" rid="B60">2002</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">French Canadian</td>
<td align="left" valign="top">Canada</td>
<td align="left" valign="top">NA (4.9)</td>
<td align="left" valign="top"><italic>GSTP1</italic> V105</td>
<td align="left" valign="top">278</td>
<td align="left" valign="top">301</td>
<td align="left" valign="top">1.5</td>
<td align="left" valign="top">1.1&#x02013;2.0</td>
<td align="left" valign="top">0.02</td>
<td align="left" valign="top">NA</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTP1</italic> V105 <italic>and GSTT1</italic> null</td>
<td align="left" valign="top">278</td>
<td align="left" valign="top">301</td>
<td align="left" valign="top">2.1</td>
<td align="left" valign="top">1.3&#x02013;3.4</td>
<td align="left" valign="top">0.003</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Gatedee et al. (<xref ref-type="bibr" rid="B35">2007</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">Thai</td>
<td align="left" valign="top">Thailand</td>
<td align="left" valign="top">0.83&#x02013;14.75 (5)</td>
<td align="left" valign="top"><italic>GSTP1</italic> V105</td>
<td align="left" valign="top">100</td>
<td align="left" valign="top">100</td>
<td align="left" valign="top">0.92</td>
<td align="left" valign="top">0.52&#x02013;1.62</td>
<td align="left" valign="top">0.886</td>
<td align="left" valign="top">Risk-adapted chemotherapy regimens modified total XII protocol (see Reference)</td>
</tr>
<tr>
<td colspan="12" align="left"><bold>RISK OF RELAPSE</bold></td>
</tr>
<tr>
<td align="left" valign="top">Stanulla et al. (<xref ref-type="bibr" rid="B91">2000</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">Germany</td>
<td align="left" valign="top">0&#x02013;18 (NA)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">64</td>
<td align="left" valign="top">64</td>
<td align="left" valign="top">0.5</td>
<td align="left" valign="top">0.23&#x02013;1.07</td>
<td align="left" valign="top">0.078</td>
<td align="left" valign="top">ALL-BFM 86 and 90 trials (see Reference)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">Austria</td>
<td colspan="1" align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">64</td>
<td align="left" valign="top">64</td>
<td align="left" valign="top">0.36</td>
<td align="left" valign="top">0.13&#x02013;0.99</td>
<td align="left" valign="top">0.048</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">Switzerland</td>
<td align="left"/>
<td align="left" valign="top"><italic>GSTP1</italic> V105 homozygote</td>
<td align="left" valign="top">64</td>
<td align="left" valign="top">64</td>
<td align="left" valign="top">0.33</td>
<td align="left" valign="top">0.09&#x02013;1.23</td>
<td align="left" valign="top">0.099</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Anderer et al. (<xref ref-type="bibr" rid="B2">2000</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">Germany</td>
<td align="left" valign="top">0&#x02013;18 (NA)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">45</td>
<td align="left" valign="top">90</td>
<td align="left" valign="top">1.13</td>
<td align="left" valign="top">0.52&#x02013;2.46</td>
<td align="left" valign="top">0.764</td>
<td align="left" valign="top">ALL-BFM 86 and 90 trials (see Reference)</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td colspan="1" align="left"/>
<td colspan="1" align="left"/>
<td colspan="1" align="left"/>
<td align="left" valign="top">Austria</td>
<td colspan="1" align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">45</td>
<td align="left" valign="top">90</td>
<td align="left" valign="top">0.18</td>
<td align="left" valign="top">0.02&#x02013;1.53</td>
<td align="left" valign="top">0.117</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">Switzerland</td>
<td align="left"/>
<td align="left" valign="top"><italic>GSTP1</italic> V105 homozygote</td>
<td align="left" valign="top">45</td>
<td align="left" valign="top">90</td>
<td align="left" valign="top">0.84</td>
<td align="left" valign="top">0.14&#x02013;4.93</td>
<td align="left" valign="top">0.851</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Takanashi et al. (<xref ref-type="bibr" rid="B93">2003</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">Japanese</td>
<td align="left" valign="top">Japan</td>
<td align="left" valign="top">1.5&#x02013;15 (NA)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">12</td>
<td align="left" valign="top">70</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">0.68</td>
<td align="left" valign="top">ALL protocol (see Reference)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">12</td>
<td align="left" valign="top">70</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">0.22</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTM1</italic> and <italic>GSTTT1</italic> null</td>
<td align="left" valign="top">12</td>
<td align="left" valign="top">70</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">0.027</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Chen et al. (<xref ref-type="bibr" rid="B17">1997</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">Black and white</td>
<td align="left" valign="top">U.S.</td>
<td align="left" valign="top">NA (NA)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">197</td>
<td align="left" valign="top">416</td>
<td align="left" valign="top">1.2</td>
<td align="left" valign="top">0.87&#x02013;</td>
<td align="left" valign="top">0.19</td>
<td align="left" valign="top">Extended intensified chemotherapy (see Reference)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">197</td>
<td align="left" valign="top">416</td>
<td align="left" valign="top">1.12</td>
<td align="left" valign="top">0.74&#x02013;</td>
<td align="left" valign="top">0.34</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">Black</td>
<td align="left"/>
<td colspan="1" align="left"/>
<td align="left" valign="top"><italic>GSTM1</italic> and <italic>GSTTT1</italic> null</td>
<td align="left" valign="top">34</td>
<td align="left" valign="top">203</td>
<td align="left" valign="top">7.36</td>
<td align="left" valign="top">2.61&#x02013;</td>
<td align="left" valign="top">0.0005</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">White</td>
<td align="left"/>
<td colspan="1" align="left"/>
<td align="left" valign="top"><italic>GSTM1</italic> and <italic>GSTTT1</italic> null</td>
<td align="left" valign="top">163</td>
<td align="left" valign="top">213</td>
<td align="left" valign="top">0.75</td>
<td align="left" valign="top">0.35&#x02013;</td>
<td align="left" valign="top">0.68</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Davies et al. (<xref ref-type="bibr" rid="B21">2002</xref>)</td>
<td align="left" valign="top">ALL</td>
<td align="left" valign="top">White</td>
<td align="left" valign="top">U.S.</td>
<td align="left" valign="top">Mostly 1-10 (NA)</td>
<td align="left" valign="top"><italic>GSTM1</italic> and <italic>GSTTT1</italic> null</td>
<td align="left" valign="top">616</td>
<td align="left" valign="top">532</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">1</td>
<td align="left" valign="top">CCG protocols (see Reference)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top">Black</td>
<td align="left"/>
<td colspan="1" align="left"/>
<td align="left" valign="top"><italic>GSTM1</italic> and <italic>GSTTT1</italic> null</td>
<td align="left" valign="top">35</td>
<td align="left" valign="top">201</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">1</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left" valign="top">Balta et al. (<xref ref-type="bibr" rid="B9">2003</xref>)</td>
<td align="left" valign="top">ALL/ANLL</td>
<td align="left" valign="top">Turkey</td>
<td align="left" valign="top">Turkey</td>
<td align="left" valign="top">0.58&#x02013;17 (6.8)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">139</td>
<td align="left" valign="top">185</td>
<td align="left" valign="top">1.03</td>
<td align="left" valign="top">0.66&#x02013;1.61</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">NA</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">139</td>
<td align="left" valign="top">185</td>
<td align="left" valign="top">0.9</td>
<td align="left" valign="top">0.53&#x02013;1.53</td>
<td align="left" valign="top">NA</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTP1</italic> V105 homozygote</td>
<td align="left" valign="top">136</td>
<td align="left" valign="top">185</td>
<td align="left" valign="top">0.75</td>
<td align="left" valign="top">0.24&#x02013;2.34</td>
<td align="left" valign="top">NA</td>
<td align="left"/>
</tr>
<tr>
<td align="left" valign="top">Zielinska et al. (<xref ref-type="bibr" rid="B110">2004</xref>)</td>
<td align="left" valign="top">ALL/AML/<break/>NHL/RMS/<break/>PNET/CNST<break/>et al</td>
<td align="left" valign="top">Polish</td>
<td align="left" valign="top">Poland</td>
<td align="left" valign="top">3.5&#x02013;12.92 (7.54)</td>
<td align="left" valign="top"><italic>GSTM1</italic> null</td>
<td align="left" valign="top">234</td>
<td align="left" valign="top">460</td>
<td align="left" valign="top">1.54</td>
<td align="left" valign="top">0.84&#x02013;2.83</td>
<td align="left" valign="top">0.16</td>
<td align="left" valign="top">Polish Paediatric Oncology Study Group recommended protocol (see Reference)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTT1</italic> null</td>
<td align="left" valign="top">234</td>
<td align="left" valign="top">460</td>
<td align="left" valign="top">1.2</td>
<td align="left" valign="top">0.6&#x02013;2.39</td>
<td align="left" valign="top">0.7</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTP1</italic> V105</td>
<td align="left" valign="top">234</td>
<td align="left" valign="top">460</td>
<td align="left" valign="top">5.7</td>
<td align="left" valign="top">2.4&#x02013;13.8</td>
<td align="left" valign="top">0.0001</td>
<td colspan="1" align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" valign="top"><italic>GSTP1</italic> I105 A114</td>
<td align="left" valign="top">234</td>
<td align="left" valign="top">460</td>
<td align="left" valign="top">3.29</td>
<td align="left" valign="top">0.73&#x02013;14.67</td>
<td align="left" valign="top">0.03</td>
<td colspan="1" align="left"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>NA, not available</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
</sec>
<sec>
<title>GST in Pediatric Cancer</title>
<sec>
<title>Epidemiology</title>
<p>As in adult cancers, a large number of epidemiological studies have tested possible associations between GST polymorphic variants as well as deletions with susceptibility of pediatric cancers (Table <xref ref-type="table" rid="T2">2</xref>). GSTM1 is subject to a deletion polymorphism that is found in as many as 75% of Caucasians (Zhong et al., <xref ref-type="bibr" rid="B109">1991</xref>; Huang et al., <xref ref-type="bibr" rid="B46">2009</xref>). Multiple case-controlled studies have indicated statistically significant associations of the GSTM1 null genotype with increased risk of childhood cancers. Groups from different regions in the world found that GSTM1 null genotype related to increased risk of acute leukemia (ALL and AML) in various populations (Krajinovic et al., <xref ref-type="bibr" rid="B59">1999</xref>; Davies et al., <xref ref-type="bibr" rid="B22">2000</xref>; Joseph et al., <xref ref-type="bibr" rid="B54">2004</xref>; Pakakasama et al., <xref ref-type="bibr" rid="B75">2005</xref>; Marino et al., <xref ref-type="bibr" rid="B64">2009</xref>). Ashton et al. (<xref ref-type="bibr" rid="B5">2007</xref>) found that GSTM1 null genotype is associated with high risk of neuroblastoma in Australia and New Zealand. GSTP1 V105 was found to relate to increased susceptibility to childhood leukemia in Canada (Krajinovic et al., <xref ref-type="bibr" rid="B60">2002</xref>). However, another group found that there was no statistically significant association between GSTP1 polymorphism and susceptibility to ALL in Thai children (Gatedee et al., <xref ref-type="bibr" rid="B35">2007</xref>). Interestingly, one group reported that GSTO1 A140D and GSTO2 N142D polymorphism were both significantly associated with susceptibility to ALL in Thailand (Pongstaporn et al., <xref ref-type="bibr" rid="B77">2009</xref>). These conflicting results were thought to be related to differences in ethnicity and age of the patients, treatment, and follow-up periods included in these studies.</p>
</sec>
<sec>
<title>GST and drug resistance</title>
<p>Glutathione <italic>S</italic>-transferases have been implicated in the development of resistance toward chemotherapeutic agents which lead to relapse in pediatric cancers (Table <xref ref-type="table" rid="T2">2</xref>). GSTT1 null genotype has been shown to confer a reduced risk of relapse in childhood ALL in several case studies (Anderer et al., <xref ref-type="bibr" rid="B2">2000</xref>; Stanulla et al., <xref ref-type="bibr" rid="B91">2000</xref>). However, the GSTT1 null genotype was also shown to be associated with an increased risk of death after chemotherapy in childhood AML (Davies et al., <xref ref-type="bibr" rid="B23">2001</xref>). As to the GSTM1&#x02013;GSTT1 double-null genotype, one group reported an increased risk of early relapse of ALL with double-null genotype (Takanashi et al., <xref ref-type="bibr" rid="B93">2003</xref>) while a subsequent study reported the opposite result (Kham et al., <xref ref-type="bibr" rid="B57">2004</xref>). Yet other studies showed that the double-null genotype was not associated with risk of relapse or treatment outcome in ALL (Chen et al., <xref ref-type="bibr" rid="B17">1997</xref>; Davies et al., <xref ref-type="bibr" rid="B21">2002</xref>; Balta et al., <xref ref-type="bibr" rid="B9">2003</xref>; Jazbec et al., <xref ref-type="bibr" rid="B50">2003</xref>). GSTP1 expression was significantly increased in relapsed AML, and GSTP1 V105 was found to be related to increased relapse rate of childhood leukemia (Sauerbrey et al., <xref ref-type="bibr" rid="B83">1994</xref>; Beck et al., <xref ref-type="bibr" rid="B10">1996</xref>; Zielinska et al., <xref ref-type="bibr" rid="B110">2004</xref>).</p>
<p>Several studies using microarray technology have identified glutathione metabolism pathway to reflect tumor resistance to chemotherapy in Ewing&#x02019;s sarcoma. The authors found that the expression of MGST1 clearly predict Ewing&#x02019;s sarcoma prognosis and to be associated with doxorubicin chemosensitivity (Townsend and Tew, <xref ref-type="bibr" rid="B103">2003</xref>; Schaefer et al., <xref ref-type="bibr" rid="B84">2008</xref>; Scotlandi et al., <xref ref-type="bibr" rid="B86">2009</xref>). In a separate microarray analysis for target genes of EWS/FLI, the master regulator of Ewing&#x02019;s sarcoma, GSTM4 was found to be upregulated by EWS/FLI. Reduction of GSTM4 levels resulted in an increased sensitivity of Ewing&#x02019;s sarcoma cells to chemotherapeutic agents (etoposide and fenretinide). This suggested a role for GSTM4 in drug resistance. In support of this hypothesis, patients with Ewing&#x02019;s sarcoma whose tumors had higher levels of GSTM4 expression had worse outcomes than those with lower expression levels (Luo et al., <xref ref-type="bibr" rid="B61">2009</xref>).</p>
<p>GSTM1 has been reported to be a significant risk factor for hematologic relapse in childhood ALL. Transduction of GSTM1 into T-acute lymphoblastic leukemia cells selectively decreased cellular sensitivity to dexamethasone in a manner that was independent of glutathione conjugation, but was due to apoptosis inhibition. Interestingly, p38-MAPK and Bim activation were suppressed, and NF-kappaB p50 was activated, in these GSTM1 expressing cells. The authors proposed that GSTM1 is a novel regulator of dexamethasone-induced apoptosis, and causes dexamethasone resistance by suppression of Bim through dual mechanisms of downregulation of p38-MAPK and up-regulation of NF-kappaB p50 (Hosono et al., <xref ref-type="bibr" rid="B40">2010</xref>). Consistently, GSTM1 null genotype was associated with a reduced risk of relapse in ALL (Stanulla et al., <xref ref-type="bibr" rid="B91">2000</xref>). Association of GSTM1 with resistance to adriamycin and cisplatin was also found in childhood hepatoblastoma (Bader et al., <xref ref-type="bibr" rid="B6">1998</xref>).</p>
<p>Drug resistance is a common problem in the treatment of childhood rhabdomyosarcoma (RMS). To identify causes of drug resistance in this disease, Seitz et al. (<xref ref-type="bibr" rid="B87">2010</xref>) performed gene expression analysis of tumors from mice transplanted with embryonal or alveolar RMS cells and treated with vincristine. The authors found 2314 differentially expressed genes between the groups in alveolar RMS and 1387 in embryonal RMS. Pathway analysis revealed a cluster of five overexpressed genes of the GST family in animals treated with vincristine, suggesting a cause for drug resistance. <italic>In vitro</italic> experiments confirmed up-regulation of GST activity following incubation with doxorubicin and topotecan in RMS cell lines. Incubation with GST inhibitors resulted in a decreased cell viability. The authors concluded that reversal of drug resistance in childhood RMS may be achieved by GST inhibitors, at least in part. Thus, the GST family represents a promising target for further treatment strategies in childhood RMS (Seitz et al., <xref ref-type="bibr" rid="B87">2010</xref>).</p>
<p>The association of GSTs with risk of relapse and drug resistance may not be a straightforward reflection of their ability to participate in detoxification reactions. Greater understanding of the numerous factors affecting GST expression and activity, as well as GST functions, may reveal further connections between GST and individual responses to disease and drugs.</p>
</sec>
<sec>
<title>Regulation of GST</title>
<p>Most cases of Ewing&#x02019;s sarcoma express the EWS/FLI fusion oncoprotein (Turc-Carel et al., <xref ref-type="bibr" rid="B104">1988</xref>). EWS/FLI functions as an aberrant transcription factor that mediates the transformed phenotype through the deregulation of several key target genes (Kinsey et al., <xref ref-type="bibr" rid="B58">2006</xref>; Owen and Lessnick, <xref ref-type="bibr" rid="B74">2006</xref>; Smith et al., <xref ref-type="bibr" rid="B90">2006</xref>; Tirado et al., <xref ref-type="bibr" rid="B100">2006</xref>; Luo et al., <xref ref-type="bibr" rid="B61">2009</xref>). Furthermore, EWS/FLI has been shown to transcriptionally activate some of its gene targets through GGAA-containing microsatellite promoter elements (Gangwal et al., <xref ref-type="bibr" rid="B33">2008</xref>). Interestingly, <italic>GSTM4</italic> contains a GGAA-microsatellite in its promoter. <italic>In vitro</italic> and <italic>in vivo</italic> studies revealed that EWS/FLI binds to the microsatellite and up-regulates <italic>GSTM4</italic> via this element. Other work has shown that the ability of EWS/FLI to activate gene expression through GGAA-microsatellite response elements is proportional to the length of the microsatellite, suggesting that microsatellite polymorphisms might affect target gene expression (Gangwal et al., <xref ref-type="bibr" rid="B32">2010</xref>). Indeed, this hypothesis was supported by the finding that the number of GGAA repeats present in the <italic>NR0B1</italic> promoter positively correlated with the level of NR0B1 mRNA expression in Ewing&#x02019;s cells (Garcia-Aragoncillo et al., <xref ref-type="bibr" rid="B34">2008</xref>). Further work will be needed to determine if a similar relationship exists for the <italic>GSTM4</italic> gene, and if such a relationship correlates with drug resistance in Ewing&#x02019;s sarcoma.</p>
<p>The GGAA-microsatellite is not shared by other GST family members, however. Other GST promoters contain response elements such as an antioxidant response element and a xenobiotic response element, as well as putative binding sites for transcription factors such as AP-1, MAF, Nrf1, Jun, Fos, and NF-kappaB. Such complex response elements suggest a mechanism for differential regulation of GST isozymes across tumor types in response to differing toxic insults.</p>
</sec>
<sec>
<title>GST as targets in pediatric cancer treatment</title>
<p>The design and discovery of compounds that bind GST isozymes and modulate their biological activity has become an important aim in cancer research because GST isozymes are overexpressed in many cancer cell lines (Tew et al., <xref ref-type="bibr" rid="B98">1996</xref>), and induce drug resistance by inactivating many chemotherapeutic compounds via GSH conjugation (Tew et al., <xref ref-type="bibr" rid="B96">1997</xref>). There are a number of candidate GST-targeted drugs at various stages of preclinical development (Tew et al., <xref ref-type="bibr" rid="B96">1997</xref>; Ruzza and Quintieri, <xref ref-type="bibr" rid="B81">2009</xref>; Wondrak, <xref ref-type="bibr" rid="B107">2009</xref>; Sau et al., <xref ref-type="bibr" rid="B82">2010</xref>). Ethacrynic acid, an inhibitor that lacks class specificity for GSTs, represented a first attempt in this direction; however, its low affinity and deleterious side effects have discouraged its use in clinical practice (Tew et al., <xref ref-type="bibr" rid="B96">1997</xref>). More recently, GSH peptidomimetic compounds have been designed, including TER 199 (Figure <xref ref-type="fig" rid="F3">3</xref>). However, many GSH derivatives are actively extruded from cancer cells by specific export pumps, such as the multidrug resistance protein, and so are unlikely to be highly efficacious (Muller et al., <xref ref-type="bibr" rid="B70">1994</xref>; Morgan et al., <xref ref-type="bibr" rid="B69">1996</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>GST as targets in pediatric cancer treatment</bold>. GST non-specific inhibitors such as ETA or TER199 decrease the GST activity in tumors and sensitize tumor cells to chemotherapeutic agents. NBDHEX treatment of tumor cells interrupts GSTP1&#x02013;JNK interaction which releases and activates JNK and results in tumor cell apoptosis. Prodrugs such as J-SK is activated specifically in tumors with high GST activity and selectively kills tumor cells.</p></caption>
<graphic xlink:href="fonc-01-00039-g003.tif"/>
</fig>
<p>A new class of GST inhibitors, called NBD derivatives, has been designed recently (Ricci et al., <xref ref-type="bibr" rid="B78">2005</xref>). A representative of this class is NBDHEX, which interacts with GSTP1 and triggers apoptosis in human tumor cells through dissociation of the JNK&#x02013;GSTP1 complex (Turella et al., <xref ref-type="bibr" rid="B105">2005</xref>; Figure <xref ref-type="fig" rid="F3">3</xref>). Osteosarcoma, Ewing&#x02019;s sarcoma, and rhabdomyosarcoma cell lines were all found to be sensitive to NBDHEX <italic>in vitro</italic> and in xenograft models (Scotlandi et al., <xref ref-type="bibr" rid="B86">2009</xref>; Pasello et al., <xref ref-type="bibr" rid="B76">2011</xref>). Importantly, NBDHEX was not extruded from tumor cells by multidrug resistance protein pumps (Ricci et al., <xref ref-type="bibr" rid="B78">2005</xref>; Turella et al., <xref ref-type="bibr" rid="B105">2005</xref>, <xref ref-type="bibr" rid="B106">2006</xref>). NBDHEX had synergistic effect with doxorubicin, vincristine, cisplatin in an <italic>in vitro</italic> study. <italic>In vivo</italic> studies confirmed the cytostatic efficacy of NBDHEX and its synergy with vincristine in Ewing&#x02019;s sarcoma cells, and also its effect against the metastatic spread of osteosarcoma cells (Pasello et al., <xref ref-type="bibr" rid="B76">2011</xref>). Although NBDHEX is still under preclinical <italic>in vivo</italic> evaluation, it may be an interesting new therapeutic option for patients who are not highly responsive to conventional regimens.</p>
<p>Another approach is to design prodrugs that exploit the high GST expression levels found in drug resistant tumors and cells. Prodrugs would be preferentially activated by GST in malignant cells, thus sparing normal tissues and enhancing the therapeutic index. JS-K is a member of the <italic>O</italic>2-aryl diazeniumdiolate compound family which was designed to release nitric oxide (NO) when activated by GSTs (Shami et al., <xref ref-type="bibr" rid="B88">2006</xref>). JS-K has shown promise as a novel cancer therapeutic agent in a number of studies. For instance, JS-K selectively induces programmed cell death in breast cancer cells while sparing normal mammary epithelial cells under the same conditions (McMurtry et al., <xref ref-type="bibr" rid="B66">2011</xref>; Figure <xref ref-type="fig" rid="F3">3</xref>). The selective anti-tumor activity of JS-K warrants its further investigation in pediatric cancers.</p>
</sec>
</sec>
<sec>
<title>Conclusion</title>
<p>Many epidemiological studies have investigated possible associations between GST polymorphisms with risk of pediatric cancers. Some studies have indicated increased risk for specific genotypes, such as the <italic>GSTT1</italic> and <italic>GSTM1</italic> deletions, while other studies have not confirmed this association. These conflicting results need to be interpreted with caution. Many GST activities other than detoxification have been discovered and may contribute to different GST activities among individuals. GSTs have also been implicated in the development of resistance toward chemotherapeutic drugs. Although further studies are required to reveal the underlying mechanisms, drugs targeting GSTs have been designed to overcome resistance to conventional therapeutic agents. Little progress has been made in understanding how GST expression and activity is regulated. Such studies will allow an understanding of the upstream players in the glutathione metabolism pathway and provide potential new approaches for the treatment of pediatric cancers.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>Stephen L. Lessnick is supported by the NIH (R21 CA138295, R01 CA140394), the Terri Anna Perine Sarcoma Fund, and the University of Utah Department of Pediatrics and Huntsman Cancer Institute/Huntsman Cancer Foundation. Joshua D. Schiffman is supported by Damon Runyon Clinical Investigator Award, Alex&#x02019;s Lemonade Stand Foundation Epidemiology Award, and the Eunice Kennedy Shriver Children&#x02019;s Health Research Career Development Award NICHD 5K12HD001410. Wen Luo is supported by the Alex&#x02019;s Lemonade Stand Foundation and the Primary Children&#x02019;s Medical Center Foundation. We also acknowledge NIH support to the Huntsman Cancer Institute (P30 CA042014).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname> <given-names>V.</given-names></name> <name><surname>Yin</surname> <given-names>Z.</given-names></name> <name><surname>Fuchs</surname> <given-names>S. Y.</given-names></name> <name><surname>Benezra</surname> <given-names>M.</given-names></name> <name><surname>Rosario</surname> <given-names>L.</given-names></name> <name><surname>Tew</surname> <given-names>K. D.</given-names></name> <name><surname>Pincus</surname> <given-names>M. R.</given-names></name> <name><surname>Sardana</surname> <given-names>M.</given-names></name> <name><surname>Henderson</surname> <given-names>C. J.</given-names></name> <name><surname>Wolf</surname> <given-names>C. R.</given-names></name> <name><surname>Davis</surname> <given-names>R. J.</given-names></name> <name><surname>Ronai</surname> <given-names>Z.</given-names></name></person-group> (<year>1999</year>). <article-title>Regulation of JNK signaling by GSTp</article-title>. <source>EMBO J.</source> <volume>18</volume>, <fpage>1321</fpage>&#x02013;<lpage>1334</lpage>.<pub-id pub-id-type="doi">10.1093/emboj/18.5.1321</pub-id><pub-id pub-id-type="pmid">10064598</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderer</surname> <given-names>G.</given-names></name> <name><surname>Schrappe</surname> <given-names>M.</given-names></name> <name><surname>Brechlin</surname> <given-names>A. M.</given-names></name> <name><surname>Lauten</surname> <given-names>M.</given-names></name> <name><surname>Muti</surname> <given-names>P.</given-names></name> <name><surname>Welte</surname> <given-names>K.</given-names></name> <name><surname>Stanulla</surname> <given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia</article-title>. <source>Pharmacogenetics</source> <volume>10</volume>, <fpage>715</fpage>&#x02013;<lpage>726</lpage>.<pub-id pub-id-type="doi">10.1097/00008571-200011000-00006</pub-id><pub-id pub-id-type="pmid">11186134</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aniya</surname> <given-names>Y.</given-names></name> <name><surname>Imaizumi</surname> <given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>Mitochondrial glutathione transferases involving a new function for membrane permeability transition pore regulation</article-title>. <source>Drug Metab. Rev.</source> <volume>43</volume>, <fpage>292</fpage>&#x02013;<lpage>299</lpage>.<pub-id pub-id-type="doi">10.3109/03602532.2011.552913</pub-id><pub-id pub-id-type="pmid">21428695</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname> <given-names>R. N.</given-names></name></person-group> (<year>1997</year>). <article-title>Structure, catalytic mechanism, and evolution of the glutathione transferases</article-title>. <source>Chem. Res. Toxicol.</source> <volume>10</volume>, <fpage>2</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1021/tx960072x</pub-id><pub-id pub-id-type="pmid">9074797</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashton</surname> <given-names>L. J.</given-names></name> <name><surname>Murray</surname> <given-names>J. E.</given-names></name> <name><surname>Haber</surname> <given-names>M.</given-names></name> <name><surname>Marshall</surname> <given-names>G. M.</given-names></name> <name><surname>Ashley</surname> <given-names>D. M.</given-names></name> <name><surname>Norris</surname> <given-names>M. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma</article-title>. <source>Pharmacogenet. Genomics</source> <volume>17</volume>, <fpage>709</fpage>&#x02013;<lpage>717</lpage>.<pub-id pub-id-type="doi">10.1097/FPC.0b013e3280e1cc92</pub-id><pub-id pub-id-type="pmid">17700360</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bader</surname> <given-names>P.</given-names></name> <name><surname>Fuchs</surname> <given-names>J.</given-names></name> <name><surname>Wenderoth</surname> <given-names>M.</given-names></name> <name><surname>von Schweinitz</surname> <given-names>D.</given-names></name> <name><surname>Niethammer</surname> <given-names>D.</given-names></name> <name><surname>Beck</surname> <given-names>J. F.</given-names></name></person-group> (<year>1998</year>). <article-title>Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin</article-title>. <source>Anticancer Res.</source> <volume>18</volume>, <fpage>3127</fpage>&#x02013;<lpage>3132</lpage>.<pub-id pub-id-type="pmid">9713521</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baez</surname> <given-names>S.</given-names></name> <name><surname>Segura-Aguilar</surname> <given-names>J.</given-names></name> <name><surname>Widersten</surname> <given-names>M.</given-names></name> <name><surname>Johansson</surname> <given-names>A. S.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name></person-group> (<year>1997</year>). <article-title>Glutathione transferases catalyse the detoxication of oxidized metabolites (?-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes</article-title>. <source>Biochem. J.</source> <volume>324</volume>, <fpage>25</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">9164836</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balogh</surname> <given-names>L. M.</given-names></name> <name><surname>Le Trong</surname> <given-names>I.</given-names></name> <name><surname>Kripps</surname> <given-names>K. A.</given-names></name> <name><surname>Shireman</surname> <given-names>L. M.</given-names></name> <name><surname>Stenkamp</surname> <given-names>R. E.</given-names></name> <name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name> <name><surname>Atkins</surname> <given-names>W. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Substrate specificity combined with stereopromiscuity in glutathione transferase A4-4-dependent metabolism of 4-hydroxynonenal</article-title>. <source>Biochemistry</source> <volume>49</volume>, <fpage>1541</fpage>&#x02013;<lpage>1548</lpage>.<pub-id pub-id-type="doi">10.1021/bi902038u</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balta</surname> <given-names>G.</given-names></name> <name><surname>Yuksek</surname> <given-names>N.</given-names></name> <name><surname>Ozyurek</surname> <given-names>E.</given-names></name> <name><surname>Ertem</surname> <given-names>U.</given-names></name> <name><surname>Hicsonmez</surname> <given-names>G.</given-names></name> <name><surname>Altay</surname> <given-names>C.</given-names></name> <name><surname>Gurgey</surname> <given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia</article-title>. <source>Am. J. Hematol.</source> <volume>73</volume>, <fpage>154</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="doi">10.1002/ajh.10339</pub-id><pub-id pub-id-type="pmid">12827651</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname> <given-names>J.</given-names></name> <name><surname>Handgretinger</surname> <given-names>R.</given-names></name> <name><surname>Klingebiel</surname> <given-names>T.</given-names></name> <name><surname>Dopfer</surname> <given-names>R.</given-names></name> <name><surname>Schaich</surname> <given-names>M.</given-names></name> <name><surname>Ehninger</surname> <given-names>G.</given-names></name> <name><surname>Niethammer</surname> <given-names>D.</given-names></name> <name><surname>Gekeler</surname> <given-names>V.</given-names></name></person-group> (<year>1996</year>). <article-title>Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML</article-title>. <source>Leukemia</source> <volume>10</volume>, <fpage>426</fpage>&#x02013;<lpage>433</lpage>.<pub-id pub-id-type="pmid">8642857</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berhane</surname> <given-names>K.</given-names></name> <name><surname>Widersten</surname> <given-names>M.</given-names></name> <name><surname>Engstrom</surname> <given-names>A.</given-names></name> <name><surname>Kozarich</surname> <given-names>J. W.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name></person-group> (<year>1994</year>). <article-title>Detoxication of base propenals and other &#x003B1;,&#x003B2;-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferase</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>91</volume>, <fpage>1480</fpage>&#x02013;<lpage>1484</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.91.4.1480</pub-id><pub-id pub-id-type="pmid">8108434</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beuckmann</surname> <given-names>C. T.</given-names></name> <name><surname>Fujimori</surname> <given-names>K.</given-names></name> <name><surname>Urade</surname> <given-names>Y.</given-names></name> <name><surname>Hayaishi</surname> <given-names>O.</given-names></name></person-group> (<year>2000</year>). <article-title>Identification of mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain</article-title>. <source>Neurochem. Res.</source> <volume>25</volume>, <fpage>733</fpage>&#x02013;<lpage>738</lpage>.<pub-id pub-id-type="doi">10.1023/A:1007579507804</pub-id><pub-id pub-id-type="pmid">10905636</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Board</surname> <given-names>P. G.</given-names></name> <name><surname>Coggan</surname> <given-names>M.</given-names></name> <name><surname>Cappello</surname> <given-names>J.</given-names></name> <name><surname>Zhou</surname> <given-names>H.</given-names></name> <name><surname>Oakley</surname> <given-names>A. J.</given-names></name> <name><surname>Anders</surname> <given-names>M. W.</given-names></name></person-group> (<year>2008</year>). <article-title>S-(4-nitrophenacyl)glutathione is a specific substrate for glutathione transferase omega 1-1</article-title>. <source>Anal. Biochem.</source> <volume>374</volume>, <fpage>25</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1016/j.ab.2007.09.029</pub-id><pub-id pub-id-type="pmid">18028863</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Board</surname> <given-names>P. G.</given-names></name> <name><surname>Coggan</surname> <given-names>M.</given-names></name> <name><surname>Chelvanavagam</surname> <given-names>G.</given-names></name> <name><surname>Easteal</surname> <given-names>S.</given-names></name> <name><surname>Jermjin</surname> <given-names>L. S.</given-names></name> <name><surname>Schulte</surname> <given-names>G. K.</given-names></name> <name><surname>Danley</surname> <given-names>D. E.</given-names></name> <name><surname>Hoth</surname> <given-names>L. R.</given-names></name> <name><surname>Griffor</surname> <given-names>M. C.</given-names></name> <name><surname>Kamath</surname> <given-names>A. V.</given-names></name> <name><surname>Rosner</surname> <given-names>M. H.</given-names></name> <name><surname>Chrunvk</surname> <given-names>B. A.</given-names></name> <name><surname>Perregaux</surname> <given-names>D. E.</given-names></name> <name><surname>Gabel</surname> <given-names>C. A.</given-names></name> <name><surname>Geoghegan</surname> <given-names>K. F.</given-names></name> <name><surname>Pandit</surname> <given-names>J.</given-names></name></person-group> (<year>2000</year>). <article-title>Identification, characterization, and crystal structure of the Omega class glutathione transferases</article-title>. <source>J. Biol. Chem.</source> <volume>275</volume>, <fpage>24798</fpage>&#x02013;<lpage>24806</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M001706200</pub-id><pub-id pub-id-type="pmid">10783391</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolt</surname> <given-names>H. M.</given-names></name> <name><surname>Their</surname> <given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology</article-title>. <source>Curr. Drug Metab.</source> <volume>7</volume>, <fpage>613</fpage>&#x02013;<lpage>628</lpage>.<pub-id pub-id-type="doi">10.2174/138920006778017786</pub-id><pub-id pub-id-type="pmid">16918316</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname> <given-names>J.</given-names></name> <name><surname>Boyland</surname> <given-names>E.</given-names></name> <name><surname>Sims</surname> <given-names>P.</given-names></name></person-group> (<year>1961</year>). <article-title>An enzyme from rat liver catalyzing conjugations with glutathione</article-title>. <source>Biochem. J.</source> <volume>79</volume>, <fpage>516</fpage>&#x02013;<lpage>524</lpage>.<pub-id pub-id-type="pmid">16748905</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C. L.</given-names></name> <name><surname>Liu</surname> <given-names>Q.</given-names></name> <name><surname>Pui</surname> <given-names>C. H.</given-names></name> <name><surname>Rivera</surname> <given-names>G. K.</given-names></name> <name><surname>Sandlund</surname> <given-names>J. T.</given-names></name> <name><surname>Ribeiro</surname> <given-names>R.</given-names></name> <name><surname>Evans</surname> <given-names>W. E.</given-names></name> <name><surname>Relling</surname> <given-names>M. V.</given-names></name></person-group> (<year>1997</year>). <article-title>Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia</article-title>. <source>Blood</source> <volume>89</volume>, <fpage>1701</fpage>&#x02013;<lpage>1707</lpage>.<pub-id pub-id-type="pmid">9057653</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>S. G.</given-names></name> <name><surname>Lee</surname> <given-names>Y. H.</given-names></name> <name><surname>Park</surname> <given-names>H. S.</given-names></name> <name><surname>Ryoo</surname> <given-names>K.</given-names></name> <name><surname>Kang</surname> <given-names>K. W.</given-names></name> <name><surname>Park</surname> <given-names>J.</given-names></name> <name><surname>Eom</surname> <given-names>S. J.</given-names></name> <name><surname>Kim</surname> <given-names>M. J.</given-names></name> <name><surname>Chang</surname> <given-names>T. S.</given-names></name> <name><surname>Choi</surname> <given-names>S. Y.</given-names></name> <name><surname>Shim</surname> <given-names>J.</given-names></name> <name><surname>Kim</surname> <given-names>Y.</given-names></name> <name><surname>Dong</surname> <given-names>M. S.</given-names></name> <name><surname>Lee</surname> <given-names>M. J.</given-names></name> <name><surname>Kim</surname> <given-names>S. G.</given-names></name> <name><surname>Ichijo</surname> <given-names>H.</given-names></name> <name><surname>Choi</surname> <given-names>E. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume>, <fpage>12749</fpage>&#x02013;<lpage>12755</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M107059200</pub-id><pub-id pub-id-type="pmid">11278289</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coles</surname> <given-names>B.</given-names></name> <name><surname>Yang</surname> <given-names>M.</given-names></name> <name><surname>Lang</surname> <given-names>N. P.</given-names></name> <name><surname>Kadlubar</surname> <given-names>F. F.</given-names></name></person-group> (<year>2000</year>). <article-title>Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (&#x0002B;)-anti benzo[a]pyrene-7,8-diol-9,10-oxide</article-title>. <source>Cancer Lett.</source> <volume>156</volume>, <fpage>167</fpage>&#x02013;<lpage>175</lpage>.<pub-id pub-id-type="doi">10.1016/S0304-3835(00)00458-4</pub-id><pub-id pub-id-type="pmid">10880766</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coombes</surname> <given-names>B.</given-names></name> <name><surname>Stakelum</surname> <given-names>G. S.</given-names></name></person-group> (<year>1961</year>). <article-title>A liver enzyme that conjugates sulfobromophthalein with glutathione</article-title>. <source>J. Clin. Invest.</source> <volume>40</volume>, <fpage>981</fpage>&#x02013;<lpage>988</lpage>.<pub-id pub-id-type="doi">10.1172/JCI104337</pub-id><pub-id pub-id-type="pmid">13694895</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>S. M.</given-names></name> <name><surname>Bhatia</surname> <given-names>S.</given-names></name> <name><surname>Ross</surname> <given-names>J. A.</given-names></name> <name><surname>Kiffmeyer</surname> <given-names>W. R.</given-names></name> <name><surname>Gaynon</surname> <given-names>P. S.</given-names></name> <name><surname>Radloff</surname> <given-names>G. A.</given-names></name> <name><surname>Robison</surname> <given-names>L. L.</given-names></name> <name><surname>Perentesis</surname> <given-names>J. P.</given-names></name></person-group> (<year>2002</year>). <article-title>Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia</article-title>. <source>Blood</source> <volume>100</volume>, <fpage>67</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2002-04-1197</pub-id><pub-id pub-id-type="pmid">12070010</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>S. M.</given-names></name> <name><surname>Robison</surname> <given-names>L. L.</given-names></name> <name><surname>Buckley</surname> <given-names>J. D.</given-names></name> <name><surname>Radloff</surname> <given-names>G. A.</given-names></name> <name><surname>Ross</surname> <given-names>J. A.</given-names></name> <name><surname>Perentesis</surname> <given-names>J. P.</given-names></name></person-group> (<year>2000</year>). <article-title>Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children&#x02019;s Cancer Group study</article-title>. <source>Cancer Epidemiol. Biomarkers Prev.</source> <volume>9</volume>, <fpage>563</fpage>&#x02013;<lpage>566</lpage>.<pub-id pub-id-type="pmid">10868689</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>S. M.</given-names></name> <name><surname>Robison</surname> <given-names>L. L.</given-names></name> <name><surname>Buckley</surname> <given-names>J. D.</given-names></name> <name><surname>Tjoa</surname> <given-names>T.</given-names></name> <name><surname>Woods</surname> <given-names>W. G.</given-names></name> <name><surname>Radloff</surname> <given-names>G. A.</given-names></name> <name><surname>Ross</surname> <given-names>J. A.</given-names></name> <name><surname>Perentesis</surname> <given-names>J. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia</article-title>. <source>J. Clin. Oncol.</source> <volume>19</volume>, <fpage>1279</fpage>&#x02013;<lpage>1287</lpage>.<pub-id pub-id-type="pmid">11230469</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Pietro</surname> <given-names>G.</given-names></name> <name><surname>Magno</surname> <given-names>L. A.</given-names></name> <name><surname>Rios-Santos</surname> <given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>Glutathione S-transferases: an overview in cancer research</article-title>. <source>Expert Opin. Drug Metab. Toxicol.</source> <volume>6</volume>, <fpage>153</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="doi">10.1517/17425250903427980</pub-id><pub-id pub-id-type="pmid">20078251</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorion</surname> <given-names>S.</given-names></name> <name><surname>Lambert</surname> <given-names>H.</given-names></name> <name><surname>Landry</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione s-transferase Mu from Ask1</article-title>. <source>J. Biol. Chem.</source> <volume>277</volume>, <fpage>30792</fpage>&#x02013;<lpage>30797</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M203642200</pub-id><pub-id pub-id-type="pmid">12077134</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doroshyenko</surname> <given-names>O.</given-names></name> <name><surname>Fuhr</surname> <given-names>U.</given-names></name> <name><surname>Kunz</surname> <given-names>D.</given-names></name> <name><surname>Frank</surname> <given-names>D.</given-names></name> <name><surname>Kinzig</surname> <given-names>M.</given-names></name> <name><surname>Jetter</surname> <given-names>A.</given-names></name> <name><surname>Reith</surname> <given-names>Y.</given-names></name> <name><surname>Lazar</surname> <given-names>A.</given-names></name> <name><surname>Taubert</surname> <given-names>D.</given-names></name> <name><surname>Kirchheiner</surname> <given-names>J.</given-names></name> <name><surname>Baum</surname> <given-names>M.</given-names></name> <name><surname>Eisenbrand</surname> <given-names>G.</given-names></name> <name><surname>Berger</surname> <given-names>F. I.</given-names></name> <name><surname>Bertow</surname> <given-names>D.</given-names></name> <name><surname>Berkessel</surname> <given-names>A.</given-names></name> <name><surname>Sorgel</surname> <given-names>F.</given-names></name> <name><surname>Schomig</surname> <given-names>E.</given-names></name> <name><surname>Tomalik-Scharte</surname> <given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans</article-title>. <source>Cancer Epidemiol. Biomarkers Prev.</source> <volume>18</volume>, <fpage>433</fpage>&#x02013;<lpage>443</lpage>.<pub-id pub-id-type="doi">10.1158/1055-9965.EPI-08-0832</pub-id><pub-id pub-id-type="pmid">19190172</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dreij</surname> <given-names>K.</given-names></name> <name><surname>Sundberg</surname> <given-names>K.</given-names></name> <name><surname>Johansson</surname> <given-names>A. S.</given-names></name> <name><surname>Nordling</surname> <given-names>E.</given-names></name> <name><surname>Seidel</surname> <given-names>A.</given-names></name> <name><surname>Persson</surname> <given-names>B.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name> <name><surname>Jernstrom</surname> <given-names>B.</given-names></name></person-group> (<year>2002</year>). <article-title>Catalytic activities of human alpha class glutathione transferases toward carcinogenic dibenzo[a,l]pyrene diol epoxides</article-title>. <source>Chem. Res. Toxicol.</source> <volume>15</volume>, <fpage>825</fpage>&#x02013;<lpage>831</lpage>.<pub-id pub-id-type="doi">10.1021/tx025519i</pub-id><pub-id pub-id-type="pmid">12067250</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dulhunty</surname> <given-names>A. F.</given-names></name> <name><surname>Hewawasam</surname> <given-names>R.</given-names></name> <name><surname>Liu</surname> <given-names>D.</given-names></name> <name><surname>Casarotto</surname> <given-names>M. G.</given-names></name> <name><surname>Board</surname> <given-names>P. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of the cardiac muscle ryanodine receptor by glutathione transferases</article-title>. <source>Drug Metab. Rev.</source> <volume>43</volume>, <fpage>236</fpage>&#x02013;<lpage>252</lpage>.<pub-id pub-id-type="doi">10.3109/03602532.2010.549134</pub-id><pub-id pub-id-type="pmid">21323602</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Economopoulos</surname> <given-names>K. P.</given-names></name> <name><surname>Sergentanis</surname> <given-names>T. N.</given-names></name></person-group> (<year>2010</year>). <article-title>GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis</article-title>. <source>Eur. J. Cancer</source> <volume>46</volume>, <fpage>1617</fpage>&#x02013;<lpage>1631</lpage>.<pub-id pub-id-type="doi">10.1016/j.ejca.2010.02.009</pub-id><pub-id pub-id-type="pmid">20207535</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elsby</surname> <given-names>R.</given-names></name> <name><surname>Kitteringham</surname> <given-names>N. R.</given-names></name> <name><surname>Goldring</surname> <given-names>C. E.</given-names></name> <name><surname>Lovatt</surname> <given-names>C. A.</given-names></name> <name><surname>Chamberlain</surname> <given-names>M.</given-names></name> <name><surname>Henderson</surname> <given-names>C. J.</given-names></name> <name><surname>Wolf</surname> <given-names>C. R.</given-names></name> <name><surname>Park</surname> <given-names>B. K.</given-names></name></person-group> (<year>2003</year>). <article-title>Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi</article-title>. <source>J. Biol. Chem.</source> <volume>278</volume>, <fpage>22243</fpage>&#x02013;<lpage>22249</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M301211200</pub-id><pub-id pub-id-type="pmid">12646564</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flanagan</surname> <given-names>J. U.</given-names></name> <name><surname>Smythe</surname> <given-names>M. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Sigma-class glutathione transferases</article-title>. <source>Drug Metab. Rev.</source> <volume>43</volume>, <fpage>194</fpage>&#x02013;<lpage>214</lpage>.<pub-id pub-id-type="doi">10.3109/03602532.2011.560157</pub-id><pub-id pub-id-type="pmid">21425928</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gangwal</surname> <given-names>K.</given-names></name> <name><surname>Close</surname> <given-names>D.</given-names></name> <name><surname>Enriquez</surname> <given-names>C. A.</given-names></name> <name><surname>Hill</surname> <given-names>C. P.</given-names></name> <name><surname>Lessnick</surname> <given-names>S. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Emergent properties of EWS/FLI regulation via GGAA microsatellites in Ewing&#x02019;s sarcoma</article-title>. <source>Genes Cancer</source> <volume>1</volume>, <fpage>177</fpage>&#x02013;<lpage>187</lpage>.<pub-id pub-id-type="doi">10.1177/1947601910361495</pub-id><pub-id pub-id-type="pmid">20827386</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gangwal</surname> <given-names>K.</given-names></name> <name><surname>Sankar</surname> <given-names>S.</given-names></name> <name><surname>Hollenhorst</surname> <given-names>P. C.</given-names></name> <name><surname>Kinsey</surname> <given-names>M.</given-names></name> <name><surname>Haroldsen</surname> <given-names>S. C.</given-names></name> <name><surname>Shah</surname> <given-names>A. A.</given-names></name> <name><surname>Boucher</surname> <given-names>K. M.</given-names></name> <name><surname>Watkins</surname> <given-names>W. S.</given-names></name> <name><surname>Jorde</surname> <given-names>L. B.</given-names></name> <name><surname>Graves</surname> <given-names>B. J.</given-names></name> <name><surname>Lessnick</surname> <given-names>S. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Microsatellites as EWS/FLI response elements in Ewing&#x02019;s sarcoma</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>105</volume>, <fpage>10149</fpage>&#x02013;<lpage>10154</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0801073105</pub-id><pub-id pub-id-type="pmid">18626011</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Aragoncillo</surname> <given-names>E.</given-names></name> <name><surname>Carillo</surname> <given-names>J.</given-names></name> <name><surname>Lalli</surname> <given-names>E.</given-names></name> <name><surname>Agra</surname> <given-names>N.</given-names></name> <name><surname>G&#x000F3;mez-L&#x000F3;pez</surname> <given-names>G.</given-names></name> <name><surname>Pesta&#x000F1;a</surname> <given-names>A.</given-names></name> <name><surname>Alonso</surname> <given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>DAX1, a direct target of EWS/FLI oncoprotein, is a principle regulator of cell-cycle progression in Ewing&#x02019;s tumor cells</article-title>. <source>Oncogene</source> <volume>27</volume>, <fpage>6034</fpage>&#x02013;<lpage>6043</lpage>.<pub-id pub-id-type="doi">10.1038/onc.2008.203</pub-id><pub-id pub-id-type="pmid">18591936</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gatedee</surname> <given-names>J.</given-names></name> <name><surname>Pakakassama</surname> <given-names>S.</given-names></name> <name><surname>Muangman</surname> <given-names>S.</given-names></name> <name><surname>Pongstaporn</surname> <given-names>W.</given-names></name></person-group> (<year>2007</year>). <article-title>Glutathione S-transferase P1 genotypes, genetic susceptibility and outcome of therapy in thai childhood acute lymphoblastic leukemia</article-title>. <source>Asian Pac. J. Cancer Prev.</source> <volume>8</volume>, <fpage>294</fpage>&#x02013;<lpage>296</lpage>.<pub-id pub-id-type="pmid">17696749</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname> <given-names>J. D.</given-names></name> <name><surname>McLellan</surname> <given-names>L. I.</given-names></name></person-group> (<year>1999</year>). <article-title>Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress</article-title>. <source>Free Radic. Res.</source> <volume>31</volume>, <fpage>273</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="doi">10.1080/10715769900300851</pub-id><pub-id pub-id-type="pmid">10517533</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname> <given-names>J. D.</given-names></name> <name><surname>Strange</surname> <given-names>R. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Glutathione s-transferase polymorphisms and their biological consequences</article-title>. <source>Pharmacology</source> <volume>61</volume>, <fpage>154</fpage>&#x02013;<lpage>166</lpage>.<pub-id pub-id-type="doi">10.1159/000028396</pub-id><pub-id pub-id-type="pmid">10971201</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname> <given-names>C. J.</given-names></name> <name><surname>Wolf</surname> <given-names>C. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Knockout and transgenic mice in glutathione transferase research</article-title>. <source>Drug Metab. Rev.</source> <volume>43</volume>, <fpage>152</fpage>&#x02013;<lpage>164</lpage>.<pub-id pub-id-type="doi">10.3109/03602532.2011.562900</pub-id><pub-id pub-id-type="pmid">21425933</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiley</surname> <given-names>C.</given-names></name> <name><surname>Bell</surname> <given-names>J.</given-names></name> <name><surname>Hume</surname> <given-names>R.</given-names></name> <name><surname>Strange</surname> <given-names>R.</given-names></name></person-group> (<year>1989</year>). <article-title>Differential expression of alpha and pi isoenzymes of glutathione s-transferase in developing human kidney</article-title>. <source>Biochim. Biophys. Acta</source> <volume>990</volume>, <fpage>321</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">2923912</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hosono</surname> <given-names>N.</given-names></name> <name><surname>Kishi</surname> <given-names>S.</given-names></name> <name><surname>Iho</surname> <given-names>S.</given-names></name> <name><surname>Urasaki</surname> <given-names>Y.</given-names></name> <name><surname>Yoshida</surname> <given-names>A.</given-names></name> <name><surname>Kurooka</surname> <given-names>H.</given-names></name> <name><surname>Yokota</surname> <given-names>Y.</given-names></name> <name><surname>Ueda</surname> <given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Glutathione s-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line</article-title>. <source>Cancer Sci.</source> <volume>101</volume>, <fpage>767</fpage>&#x02013;<lpage>773</lpage>.<pub-id pub-id-type="doi">10.1111/j.1349-7006.2009.01432.x</pub-id><pub-id pub-id-type="pmid">20067466</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>X.</given-names></name> <name><surname>Ji</surname> <given-names>X.</given-names></name> <name><surname>Srivastava</surname> <given-names>S. K.</given-names></name> <name><surname>Xia</surname> <given-names>H.</given-names></name> <name><surname>Awasthi</surname> <given-names>S.</given-names></name> <name><surname>Nanduri</surname> <given-names>B.</given-names></name> <name><surname>Awasthi</surname> <given-names>Y. C.</given-names></name> <name><surname>Zimniak</surname> <given-names>P.</given-names></name> <name><surname>Singh</surname> <given-names>S. V.</given-names></name></person-group> (<year>1997a</year>). <article-title>Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxides of chrysene</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>345</volume>, <fpage>32</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1006/abbi.1997.0270</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>X.</given-names></name> <name><surname>O&#x02019;Donnell</surname> <given-names>R.</given-names></name> <name><surname>Srivastava</surname> <given-names>S. K.</given-names></name> <name><surname>Xia</surname> <given-names>H.</given-names></name> <name><surname>Zimniak</surname> <given-names>P.</given-names></name> <name><surname>Nanduri</surname> <given-names>B.</given-names></name> <name><surname>Bleicher</surname> <given-names>R. J.</given-names></name> <name><surname>Awasthi</surname> <given-names>S.</given-names></name> <name><surname>Awasthi</surname> <given-names>Y. C.</given-names></name> <name><surname>Ji</surname> <given-names>X.</given-names></name> <name><surname>Singh</surname> <given-names>S. V.</given-names></name></person-group> (<year>1997b</year>). <article-title>Active site architecture of polymorphic forms of human glutathione S-transferase P1-1 accounts for their enantioselectivity and disparate activity in the glutathione conjugation of 7&#x003B2;,8&#x003B1;-dihydroxy-9&#x003B1;,10&#x003B1;-oxy-7,8,9,10-tetrahydrobenzo(&#x003B1;)pyrene</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>235</volume>, <fpage>424</fpage>&#x02013;<lpage>428</lpage>.<pub-id pub-id-type="doi">10.1006/bbrc.1997.6777</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>X.</given-names></name> <name><surname>Xia</surname> <given-names>H.</given-names></name> <name><surname>Srivastava</surname> <given-names>S. K.</given-names></name> <name><surname>Herzog</surname> <given-names>C.</given-names></name> <name><surname>Awasthi</surname> <given-names>Y. C.</given-names></name> <name><surname>Ji</surname> <given-names>X.</given-names></name> <name><surname>Zimniak</surname> <given-names>P.</given-names></name> <name><surname>Singh</surname> <given-names>S. V.</given-names></name></person-group> (<year>1997c</year>). <article-title>Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>238</volume>, <fpage>397</fpage>&#x02013;<lpage>402</lpage>.<pub-id pub-id-type="doi">10.1006/bbrc.1997.7311</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>X.</given-names></name> <name><surname>Xia</surname> <given-names>H.</given-names></name> <name><surname>Srivastava</surname> <given-names>S. K.</given-names></name> <name><surname>Pal</surname> <given-names>A.</given-names></name> <name><surname>Awasthi</surname> <given-names>Y. C.</given-names></name> <name><surname>Zimniak</surname> <given-names>P.</given-names></name> <name><surname>Singh</surname> <given-names>S. V.</given-names></name></person-group> (<year>1998</year>). <article-title>Catalytic efficiencies of allelic variants of human glutathione &#x02013;transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene</article-title>. <source>Cancer Res.</source> <volume>58</volume>, <fpage>5340</fpage>&#x02013;<lpage>5343</lpage>.<pub-id pub-id-type="pmid">9850062</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>C. Y.</given-names></name> <name><surname>Huang</surname> <given-names>K. L.</given-names></name> <name><surname>Cheng</surname> <given-names>T. J.</given-names></name> <name><surname>Wang</surname> <given-names>J. D.</given-names></name> <name><surname>Hsieh</surname> <given-names>L. L.</given-names></name></person-group> (<year>1997</year>). <article-title>The GST T1 and CYP2E1 genotypes are possible factors causing vinyl chloride induced abnormal liver function</article-title>. <source>Arch. Toxicol.</source> <volume>71</volume>, <fpage>482</fpage>&#x02013;<lpage>488</lpage>.<pub-id pub-id-type="doi">10.1007/s002040050416</pub-id><pub-id pub-id-type="pmid">9248625</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>J. X.</given-names></name> <name><surname>Li</surname> <given-names>F. Y.</given-names></name> <name><surname>Xiao</surname> <given-names>W.</given-names></name> <name><surname>Song</surname> <given-names>Z. X.</given-names></name> <name><surname>Qian</surname> <given-names>R. Y.</given-names></name> <name><surname>Chen</surname> <given-names>P.</given-names></name> <name><surname>Salminen</surname> <given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Expression of thymidylate synthase and glutathione-s-transferase pi in patients with esophageal squamous cell carcinoma</article-title>. <source>World J. Gastroenterol.</source> <volume>15</volume>, <fpage>4316</fpage>&#x02013;<lpage>4321</lpage>.<pub-id pub-id-type="doi">10.3748/wjg.15.4044</pub-id><pub-id pub-id-type="pmid">19750576</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hubatsch</surname> <given-names>I.</given-names></name> <name><surname>Ridderstrom</surname> <given-names>M.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name></person-group> (<year>1998</year>). <article-title>Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation</article-title>. <source>Biochem. J.</source> <volume>330</volume>, <fpage>175</fpage>&#x02013;<lpage>179</lpage>.<pub-id pub-id-type="pmid">9461507</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jakobsson</surname> <given-names>P. J.</given-names></name> <name><surname>Mancini</surname> <given-names>J. A.</given-names></name> <name><surname>Ford-Hutchinson</surname> <given-names>A. W.</given-names></name></person-group> (<year>1996</year>). <article-title>Identification and characterization of a novel human microsomal glutathione S-transferase with leukotrience C4 synthase activity and significant sequence identity to 5-lipoxygenase-activating protein and leukotriene C4 synthase</article-title>. <source>J. Biol. Chem.</source> <volume>271</volume>, <fpage>22203</fpage>&#x02013;<lpage>22210</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.271.36.22203</pub-id><pub-id pub-id-type="pmid">8703034</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jakobsson</surname> <given-names>P. J.</given-names></name> <name><surname>Mancini</surname> <given-names>J. A.</given-names></name> <name><surname>Riendeau</surname> <given-names>D.</given-names></name> <name><surname>Ford-Hutchinson</surname> <given-names>A. W.</given-names></name></person-group> (<year>1997</year>). <article-title>Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities</article-title>. <source>J. Biol. Chem.</source> <volume>272</volume>, <fpage>22934</fpage>&#x02013;<lpage>22939</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.272.15.10182</pub-id><pub-id pub-id-type="pmid">9278457</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jazbec</surname> <given-names>J.</given-names></name> <name><surname>Aplenc</surname> <given-names>R.</given-names></name> <name><surname>Dolzan</surname> <given-names>V.</given-names></name> <name><surname>Debeljak</surname> <given-names>M.</given-names></name> <name><surname>Jereb</surname> <given-names>B.</given-names></name></person-group> (<year>2003</year>). <article-title>GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia</article-title>. <source>Leukemia</source> <volume>17</volume>, <fpage>2540</fpage>&#x02013;<lpage>2542</lpage>.<pub-id pub-id-type="doi">10.1038/sj.leu.2403164</pub-id><pub-id pub-id-type="pmid">14523457</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname> <given-names>A. S.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name></person-group> (<year>2001</year>). <article-title>Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume>, <fpage>33061</fpage>&#x02013;<lpage>33065</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M108842200</pub-id><pub-id pub-id-type="pmid">11418619</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname> <given-names>K.</given-names></name> <name><surname>Jarvliden</surname> <given-names>J.</given-names></name> <name><surname>Gogvadze</surname> <given-names>V.</given-names></name> <name><surname>Morgenstern</surname> <given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Multiple roles of microsomal glutathione transferase 1 in cellular protection: a mechanistic study</article-title>. <source>Free Radic. Biol. Med.</source> <volume>49</volume>, <fpage>1638</fpage>&#x02013;<lpage>1645</lpage>.<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.08.013</pub-id><pub-id pub-id-type="pmid">20727966</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>W. W.</given-names></name> <name><surname>Ueng</surname> <given-names>Y. F.</given-names></name> <name><surname>Widersten</surname> <given-names>W.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name> <name><surname>Hayes</surname> <given-names>J. D.</given-names></name> <name><surname>Sherratt</surname> <given-names>P. J.</given-names></name> <name><surname>Ketterer</surname> <given-names>B.</given-names></name> <name><surname>Guengerich</surname> <given-names>F. P.</given-names></name></person-group> (<year>1997</year>). <article-title>Conjugation of highly reactive aflatoxin B1 exo-8,9-epoxide catalysed by rat and human glutathione transferases: estimation of kinetic parameters</article-title>. <source>Biochemistry</source> <volume>36</volume>, <fpage>3056</fpage>&#x02013;<lpage>3060</lpage>.<pub-id pub-id-type="doi">10.1021/bi971608w</pub-id><pub-id pub-id-type="pmid">9115980</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname> <given-names>T.</given-names></name> <name><surname>Kusumakumary</surname> <given-names>P.</given-names></name> <name><surname>Chacko</surname> <given-names>P.</given-names></name> <name><surname>Abraham</surname> <given-names>A.</given-names></name> <name><surname>Pillai</surname> <given-names>M. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children</article-title>. <source>Pediatr. Blood Cancer</source> <volume>43</volume>, <fpage>560</fpage>&#x02013;<lpage>567</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.20074</pub-id><pub-id pub-id-type="pmid">15382273</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Josephy</surname> <given-names>P. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology</article-title>. <source>Hum. Genomics Proteomics</source> <volume>2010</volume>, <fpage>876940</fpage>&#x02013;<lpage>876953</lpage>.<pub-id pub-id-type="pmid">20981235</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanaoka</surname> <given-names>Y.</given-names></name> <name><surname>Ago</surname> <given-names>H.</given-names></name> <name><surname>Inagaki</surname> <given-names>E.</given-names></name> <name><surname>Nanayama</surname> <given-names>T.</given-names></name> <name><surname>Miyano</surname> <given-names>M.</given-names></name> <name><surname>Kikuno</surname> <given-names>R.</given-names></name> <name><surname>Fujii</surname> <given-names>Y.</given-names></name> <name><surname>Eguchi</surname> <given-names>N.</given-names></name> <name><surname>Toh</surname> <given-names>H.</given-names></name> <name><surname>Urade</surname> <given-names>Y.</given-names></name> <name><surname>Hayaishi</surname> <given-names>O.</given-names></name></person-group> (<year>1997</year>). <article-title>Cloning and crystal structure of hematopoietic prostaglandin D synthase</article-title>. <source>Cell</source> <volume>90</volume>, <fpage>1085</fpage>&#x02013;<lpage>1095</lpage>.<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80374-8</pub-id><pub-id pub-id-type="pmid">9323136</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kham</surname> <given-names>S. K.</given-names></name> <name><surname>Soh</surname> <given-names>C. K.</given-names></name> <name><surname>Heng</surname> <given-names>C. K.</given-names></name> <name><surname>Ariffin</surname> <given-names>H.</given-names></name> <name><surname>Quah</surname> <given-names>T. C.</given-names></name> <name><surname>Yeoh</surname> <given-names>A. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Double deletions of glutathione S-transferase genes (GSTM1 and GSTT1) reduce the risk of early relapse in childhood B-lineage acute lymphoblastic leukaemia (ALL)</article-title>. <source>Ann. Acad. Med. Singapore</source> <volume>33</volume>, <fpage>S83</fpage>&#x02013;<lpage>S85</lpage>.<pub-id pub-id-type="pmid">15651226</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kinsey</surname> <given-names>M.</given-names></name> <name><surname>Smith</surname> <given-names>R.</given-names></name> <name><surname>Lessnick</surname> <given-names>S. L.</given-names></name></person-group> (<year>2006</year>). <article-title>NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing&#x02019;s sarcoma</article-title>. <source>Mol. Cancer Res.</source> <volume>4</volume>, <fpage>851</fpage>&#x02013;<lpage>859</lpage>.<pub-id pub-id-type="doi">10.1158/1541-7786.MCR-06-0090</pub-id><pub-id pub-id-type="pmid">17114343</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krajinovic</surname> <given-names>M.</given-names></name> <name><surname>Labuda</surname> <given-names>D.</given-names></name> <name><surname>Richer</surname> <given-names>C.</given-names></name> <name><surname>Karimi</surname> <given-names>S.</given-names></name> <name><surname>Sinnett</surname> <given-names>D.</given-names></name></person-group> (<year>1999</year>). <article-title>Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms</article-title>. <source>Blood</source> <volume>93</volume>, <fpage>1496</fpage>&#x02013;<lpage>1501</lpage>.<pub-id pub-id-type="pmid">10029576</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krajinovic</surname> <given-names>M.</given-names></name> <name><surname>Labuda</surname> <given-names>D.</given-names></name> <name><surname>Sinnett</surname> <given-names>D.</given-names></name></person-group> (<year>2002</year>). <article-title>Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia</article-title>. <source>Pharmacogenetics</source> <volume>12</volume>, <fpage>655</fpage>&#x02013;<lpage>658</lpage>.<pub-id pub-id-type="doi">10.1097/00008571-200211000-00010</pub-id><pub-id pub-id-type="pmid">12439226</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>W.</given-names></name> <name><surname>Gangwal</surname> <given-names>K.</given-names></name> <name><surname>Sankar</surname> <given-names>S.</given-names></name> <name><surname>Boucher</surname> <given-names>K. M.</given-names></name> <name><surname>Thomas</surname> <given-names>D.</given-names></name> <name><surname>Lessnick</surname> <given-names>S. L.</given-names></name></person-group> (<year>2009</year>). <article-title>GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing&#x02019;s sarcoma oncogenesis and therapeutic resistance</article-title>. <source>Oncogene</source> <volume>28</volume>, <fpage>4126</fpage>&#x02013;<lpage>4132</lpage>.<pub-id pub-id-type="doi">10.1038/onc.2009.262</pub-id><pub-id pub-id-type="pmid">19718047</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mancini</surname> <given-names>J. A.</given-names></name> <name><surname>Abramovitz</surname> <given-names>M.</given-names></name> <name><surname>Cox</surname> <given-names>M. E.</given-names></name> <name><surname>Wong</surname> <given-names>E.</given-names></name> <name><surname>Charleson</surname> <given-names>S.</given-names></name> <name><surname>Perrier</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Prasit</surname> <given-names>P.</given-names></name> <name><surname>Vickers</surname> <given-names>P. J.</given-names></name></person-group> (<year>1993</year>). <article-title>5-lipoxygenase-activating protein is an arachidonate binding protein</article-title>. <source>FEBS Lett.</source> <volume>318</volume>, <fpage>277</fpage>&#x02013;<lpage>281</lpage>.<pub-id pub-id-type="doi">10.1016/0014-5793(93)80528-3</pub-id><pub-id pub-id-type="pmid">8440384</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mancini</surname> <given-names>J. A.</given-names></name> <name><surname>Blood</surname> <given-names>K.</given-names></name> <name><surname>Guay</surname> <given-names>J.</given-names></name> <name><surname>Gordon</surname> <given-names>R.</given-names></name> <name><surname>Claveau</surname> <given-names>D.</given-names></name> <name><surname>Chan</surname> <given-names>C. C.</given-names></name> <name><surname>Riendeau</surname> <given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis</article-title>. <source>J. Biol. Chem.</source> <volume>279</volume>, <fpage>4469</fpage>&#x02013;<lpage>4475</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M006865200</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marino</surname> <given-names>S.</given-names></name> <name><surname>Verzegnassi</surname> <given-names>F.</given-names></name> <name><surname>Tamaro</surname> <given-names>P.</given-names></name> <name><surname>Stocco</surname> <given-names>G.</given-names></name> <name><surname>Bartoli</surname> <given-names>F.</given-names></name> <name><surname>Decorti</surname> <given-names>G.</given-names></name> <name><surname>Rabusin</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response</article-title>. <source>Pediatr. Blood Cancer</source> <volume>53</volume>, <fpage>984</fpage>&#x02013;<lpage>991</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.22163</pub-id><pub-id pub-id-type="pmid">19621425</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname> <given-names>B. A.</given-names></name> <name><surname>Koyner</surname> <given-names>J. L.</given-names></name> <name><surname>Murray</surname> <given-names>P. T.</given-names></name></person-group> (<year>2010</year>). <article-title>Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery: a critical review</article-title>. <source>Curr. Opin. Crit. Care</source> <volume>16</volume>, <fpage>550</fpage>&#x02013;<lpage>555</lpage>.<pub-id pub-id-type="doi">10.1097/MCC.0b013e32833fdd9a</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McMurtry</surname> <given-names>V.</given-names></name> <name><surname>Saavedra</surname> <given-names>J. E.</given-names></name> <name><surname>Nieves-Alicea</surname> <given-names>R.</given-names></name> <name><surname>Simeone</surname> <given-names>A. M.</given-names></name> <name><surname>Keefer</surname> <given-names>L. K.</given-names></name> <name><surname>Tari</surname> <given-names>A. M.</given-names></name></person-group> (<year>2011</year>). <article-title>JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells</article-title>. <source>Int. J. Oncol.</source> <volume>38</volume>, <fpage>963</fpage>&#x02013;<lpage>971</lpage>.<pub-id pub-id-type="pmid">21271218</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mileo</surname> <given-names>A. M.</given-names></name> <name><surname>Abbruzzese</surname> <given-names>C.</given-names></name> <name><surname>Mattarocci</surname> <given-names>S.</given-names></name> <name><surname>Bellacchio</surname> <given-names>E.</given-names></name> <name><surname>Pisano</surname> <given-names>P.</given-names></name> <name><surname>Federico</surname> <given-names>A.</given-names></name> <name><surname>Maresca</surname> <given-names>V.</given-names></name> <name><surname>Picardo</surname> <given-names>M.</given-names></name> <name><surname>Giorgi</surname> <given-names>A.</given-names></name> <name><surname>Maras</surname> <given-names>B.</given-names></name> <name><surname>Schinin&#x000E0;</surname> <given-names>M. E.</given-names></name> <name><surname>Paggi</surname> <given-names>M. G.</given-names></name></person-group> (<year>2009</year>). <article-title>Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival</article-title>. <source>PLoS ONE</source> <volume>4</volume>, <fpage>e7254</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0007254</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minelli</surname> <given-names>C.</given-names></name> <name><surname>Granell</surname> <given-names>R.</given-names></name> <name><surname>Newson</surname> <given-names>R.</given-names></name> <name><surname>Rose-Zerilli</surname> <given-names>M. J.</given-names></name> <name><surname>Torrent</surname> <given-names>M.</given-names></name> <name><surname>Ring</surname> <given-names>S. M.</given-names></name> <name><surname>Holloway</surname> <given-names>J. W.</given-names></name> <name><surname>Shaheen</surname> <given-names>S. O.</given-names></name> <name><surname>Henderson</surname> <given-names>J. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Glutathione-S-transferase genes and asthma phenotypes: a human genome epidemiology (HuGE) systematic review and meta-analysis including unpublished data</article-title>. <source>Int. J. Epidemiol.</source> <volume>39</volume>, <fpage>539</fpage>&#x02013;<lpage>562</lpage>.<pub-id pub-id-type="doi">10.1093/ije/dyp337</pub-id><pub-id pub-id-type="pmid">20032267</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname> <given-names>A. S.</given-names></name> <name><surname>Ciaccio</surname> <given-names>P. J.</given-names></name> <name><surname>Tew</surname> <given-names>K. D.</given-names></name> <name><surname>Kauvar</surname> <given-names>L. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines</article-title>. <source>Cancer Chemother. Pharmacol.</source> <volume>37</volume>, <fpage>363</fpage>&#x02013;<lpage>370</lpage>.</citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname> <given-names>M.</given-names></name> <name><surname>Meijer</surname> <given-names>C.</given-names></name> <name><surname>Zaman</surname> <given-names>G. J.</given-names></name> <name><surname>Borst</surname> <given-names>P.</given-names></name> <name><surname>Scheper</surname> <given-names>R. J.</given-names></name> <name><surname>Mulder</surname> <given-names>N. H.</given-names></name> <name><surname>de Vries</surname> <given-names>E. G.</given-names></name> <name><surname>Jansen</surname> <given-names>P. L.</given-names></name></person-group> (<year>1994</year>). <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>91</volume>, <fpage>13033</fpage>&#x02013;<lpage>13037</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.91.22.10581</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname> <given-names>Y.</given-names></name> <name><surname>Ohigashi</surname> <given-names>H.</given-names></name> <name><surname>Masuda</surname> <given-names>S.</given-names></name> <name><surname>Murakami</surname> <given-names>A.</given-names></name> <name><surname>Morimitsu</surname> <given-names>Y.</given-names></name> <name><surname>Kawamoto</surname> <given-names>Y.</given-names></name> <name><surname>Osawa</surname> <given-names>T.</given-names></name> <name><surname>Imagawa</surname> <given-names>M.</given-names></name> <name><surname>Uchida</surname> <given-names>K.</given-names></name></person-group> (<year>2000</year>). <article-title>Redox regulation of glutathione S-transferase induction by benzyl isothiocyanate: correlation of enzyme induction with the formation of reactive oxygen intermediates</article-title>. <source>Cancer Res.</source> <volume>60</volume>, <fpage>219</fpage>&#x02013;<lpage>225</lpage>.<pub-id pub-id-type="pmid">10667562</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norrgard</surname> <given-names>M. A.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Engineering GST M2-2 for high activity with indene 1,2-oxide and indication of an H-site residue sustaining catalytic promiscuity</article-title>. <source>J. Mol. Biol.</source> <volume>412</volume>, <fpage>111</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="doi">10.1016/j.jmb.2011.07.039</pub-id><pub-id pub-id-type="pmid">21821040</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname> <given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Glutathione transferases: a structural perspective</article-title>. <source>Drug Metab. Rev.</source> <volume>43</volume>, <fpage>138</fpage>&#x02013;<lpage>151</lpage>.<pub-id pub-id-type="doi">10.3109/03602532.2011.558093</pub-id><pub-id pub-id-type="pmid">21428697</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname> <given-names>L. A.</given-names></name> <name><surname>Lessnick</surname> <given-names>S. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing&#x02019;s sarcoma</article-title>. <source>Cell Cycle</source> <volume>5</volume>, <fpage>2049</fpage>&#x02013;<lpage>2053</lpage>.<pub-id pub-id-type="doi">10.4161/cc.5.18.3213</pub-id><pub-id pub-id-type="pmid">16969112</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pakakasama</surname> <given-names>S.</given-names></name> <name><surname>Mukda</surname> <given-names>E.</given-names></name> <name><surname>Sasanakul</surname> <given-names>W.</given-names></name> <name><surname>Kadegasem</surname> <given-names>P.</given-names></name> <name><surname>Udomsubpayakul</surname> <given-names>U.</given-names></name> <name><surname>Thithapandha</surname> <given-names>A.</given-names></name> <name><surname>Hongeng</surname> <given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia</article-title>. <source>Am. J. Hematol.</source> <volume>79</volume>, <fpage>202</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="doi">10.1002/ajh.20404</pub-id><pub-id pub-id-type="pmid">15981231</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasello</surname> <given-names>M.</given-names></name> <name><surname>Manara</surname> <given-names>M. C.</given-names></name> <name><surname>Michelacci</surname> <given-names>F.</given-names></name> <name><surname>Fanelli</surname> <given-names>M.</given-names></name> <name><surname>Hattinger</surname> <given-names>C. M.</given-names></name> <name><surname>Nicoletti</surname> <given-names>G.</given-names></name> <name><surname>Landuzzi</surname> <given-names>L.</given-names></name> <name><surname>Lollini</surname> <given-names>P. L.</given-names></name> <name><surname>Caccuri</surname> <given-names>A.</given-names></name> <name><surname>Picci</surname> <given-names>P.</given-names></name> <name><surname>Scotlandi</surname> <given-names>K.</given-names></name> <name><surname>Serra</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Targeting glutathione-s transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy</article-title>. <source>Anal. Cell. Pathol. (Amst.)</source> <volume>34</volume>, <fpage>131</fpage>&#x02013;<lpage>145</lpage>.<pub-id pub-id-type="pmid">21673434</pub-id></citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pongstaporn</surname> <given-names>W.</given-names></name> <name><surname>Pakakasama</surname> <given-names>S.</given-names></name> <name><surname>Sanguansin</surname> <given-names>S.</given-names></name> <name><surname>Hongeng</surname> <given-names>S.</given-names></name> <name><surname>Petmitr</surname> <given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Polymorphism of glutathione S-transferase Omega gene: association with risk of childhood acute lymphoblastic leukemia</article-title>. <source>J. Cancer Res. Clin. Oncol.</source> <volume>135</volume>, <fpage>673</fpage>&#x02013;<lpage>678</lpage>.<pub-id pub-id-type="doi">10.1007/s00432-008-0501-4</pub-id><pub-id pub-id-type="pmid">18941778</pub-id></citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ricci</surname> <given-names>G.</given-names></name> <name><surname>De Maria</surname> <given-names>F.</given-names></name> <name><surname>Antonini</surname> <given-names>G.</given-names></name> <name><surname>Turella</surname> <given-names>P.</given-names></name> <name><surname>Bullo</surname> <given-names>A.</given-names></name> <name><surname>Stella</surname> <given-names>L.</given-names></name> <name><surname>Filomeni</surname> <given-names>G.</given-names></name> <name><surname>Caccuri</surname> <given-names>A. M.</given-names></name></person-group> (<year>2005</year>). <article-title>7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione s-transferases</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume>, <fpage>26397</fpage>&#x02013;<lpage>26405</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M503295200</pub-id><pub-id pub-id-type="pmid">15888444</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>A.</given-names></name> <name><surname>Huttley</surname> <given-names>G. A.</given-names></name> <name><surname>Booth</surname> <given-names>H. S.</given-names></name> <name><surname>Board</surname> <given-names>P. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Modelling and bioinformatics studies of the human Kappa-class glutathione transferase predict a novel third glutathione transferase family with similarity to prokaryotic 2-hydroxychromene-2-carboxylate isomerases</article-title>. <source>Biochem. J.</source> <volume>379</volume>, <fpage>541</fpage>&#x02013;<lpage>552</lpage>.<pub-id pub-id-type="doi">10.1042/BJ20031656</pub-id><pub-id pub-id-type="pmid">14709161</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname> <given-names>L.</given-names></name> <name><surname>Andrews</surname> <given-names>K.</given-names></name> <name><surname>Ng</surname> <given-names>L.</given-names></name> <name><surname>O&#x02019;Rourke</surname> <given-names>K.</given-names></name> <name><surname>Maslen</surname> <given-names>A.</given-names></name> <name><surname>Kirby</surname> <given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Human GSTA-1 reduces c-Jun N-terminal kinase signaling and apoptosis in Caco-2 cells</article-title>. <source>Biochem. J.</source> <volume>400</volume>, <fpage>135</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="doi">10.1042/BJ20060110</pub-id><pub-id pub-id-type="pmid">16836488</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruzza</surname> <given-names>P.</given-names></name> <name><surname>Quintieri</surname> <given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Enzymes as useful tools and potential targets in cancer chemotherapy</article-title>. <source>Anticancer Agents Med. Chem.</source> <volume>9</volume>, <fpage>716</fpage>.<pub-id pub-id-type="pmid">19799529</pub-id></citation></ref>
<ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sau</surname> <given-names>A.</given-names></name> <name><surname>Pellizzari Tregno</surname> <given-names>F.</given-names></name> <name><surname>Valentino</surname> <given-names>F.</given-names></name> <name><surname>Federici</surname> <given-names>G.</given-names></name> <name><surname>Caccuri</surname> <given-names>A. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Glutathione transferases and development of new principles to overcome drug resistance</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>500</volume>, <fpage>116</fpage>&#x02013;<lpage>122</lpage>.<pub-id pub-id-type="doi">10.1016/j.abb.2010.05.012</pub-id><pub-id pub-id-type="pmid">20494652</pub-id></citation></ref>
<ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sauerbrey</surname> <given-names>A.</given-names></name> <name><surname>Zintl</surname> <given-names>F.</given-names></name> <name><surname>Volm</surname> <given-names>M.</given-names></name></person-group> (<year>1994</year>). <article-title>P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia</article-title>. <source>Br. J. Cancer</source> <volume>70</volume>, <fpage>1144</fpage>&#x02013;<lpage>1149</lpage>.<pub-id pub-id-type="doi">10.1038/bjc.1994.462</pub-id><pub-id pub-id-type="pmid">7981066</pub-id></citation></ref>
<ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname> <given-names>K. L.</given-names></name> <name><surname>Eisenacher</surname> <given-names>M.</given-names></name> <name><surname>Braun</surname> <given-names>Y.</given-names></name> <name><surname>Brachwitz</surname> <given-names>K.</given-names></name> <name><surname>Wai</surname> <given-names>D. H.</given-names></name> <name><surname>Dirksen</surname> <given-names>U.</given-names></name> <name><surname>Lanvers-Kaminsky</surname> <given-names>C.</given-names></name> <name><surname>Juergens</surname> <given-names>H.</given-names></name> <name><surname>Herrero</surname> <given-names>D.</given-names></name> <name><surname>Stegmaier</surname> <given-names>S.</given-names></name> <name><surname>Koscielniak</surname> <given-names>E.</given-names></name> <name><surname>Eggert</surname> <given-names>A.</given-names></name> <name><surname>Nathrath</surname> <given-names>M.</given-names></name> <name><surname>Gosheger</surname> <given-names>G.</given-names></name> <name><surname>Schneider</surname> <given-names>D. T.</given-names></name> <name><surname>Bury</surname> <given-names>C.</given-names></name> <name><surname>Diallo-Danebrock</surname> <given-names>R.</given-names></name> <name><surname>Ottaviano</surname> <given-names>L.</given-names></name> <name><surname>Gabbert</surname> <given-names>H. E.</given-names></name> <name><surname>Poremba</surname> <given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Microarray analysis of Ewing&#x02019;s sarcoma family of tumors reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy</article-title>. <source>Eur. J. Cancer</source> <volume>44</volume>, <fpage>699</fpage>&#x02013;<lpage>709</lpage>.<pub-id pub-id-type="doi">10.1016/j.ejca.2008.01.020</pub-id><pub-id pub-id-type="pmid">18294840</pub-id></citation></ref>
<ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schaffert</surname> <given-names>C. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Role of MGST1 in reactive intermediate-induced injury</article-title>. <source>World J. Gastroenterol.</source> <volume>17</volume>, <fpage>2552</fpage>&#x02013;<lpage>2557</lpage>.<pub-id pub-id-type="doi">10.3748/wjg.v17.i20.2552</pub-id><pub-id pub-id-type="pmid">21633660</pub-id></citation></ref>
<ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scotlandi</surname> <given-names>K.</given-names></name> <name><surname>Remondini</surname> <given-names>D.</given-names></name> <name><surname>Castellani</surname> <given-names>G.</given-names></name> <name><surname>Manara</surname> <given-names>M. C.</given-names></name> <name><surname>Nardi</surname> <given-names>F.</given-names></name> <name><surname>Cantiani</surname> <given-names>L.</given-names></name> <name><surname>Francesconi</surname> <given-names>M.</given-names></name> <name><surname>Mercuri</surname> <given-names>M.</given-names></name> <name><surname>Caccuri</surname> <given-names>A. M.</given-names></name> <name><surname>Serra</surname> <given-names>M.</given-names></name> <name><surname>Knuutila</surname> <given-names>S.</given-names></name> <name><surname>Picci</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome</article-title>. <source>J. Clin. Oncol.</source> <volume>27</volume>, <fpage>2209</fpage>&#x02013;<lpage>2216</lpage>.<pub-id pub-id-type="doi">10.1200/JCO.2008.19.2542</pub-id><pub-id pub-id-type="pmid">19307502</pub-id></citation></ref>
<ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seitz</surname> <given-names>G.</given-names></name> <name><surname>Bonin</surname> <given-names>M.</given-names></name> <name><surname>Fuchs</surname> <given-names>J.</given-names></name> <name><surname>Poths</surname> <given-names>S.</given-names></name> <name><surname>Ruck</surname> <given-names>P.</given-names></name> <name><surname>Warmann</surname> <given-names>S. W.</given-names></name> <name><surname>Armeanu-Ebinger</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Inhibition of glutathione-s-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma</article-title>. <source>Int. J. Oncol.</source> <volume>36</volume>, <fpage>491</fpage>&#x02013;<lpage>500</lpage>.<pub-id pub-id-type="pmid">20043085</pub-id></citation></ref>
<ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shami</surname> <given-names>P. J.</given-names></name> <name><surname>Saavedra</surname> <given-names>J. E.</given-names></name> <name><surname>Bonifant</surname> <given-names>C. L.</given-names></name> <name><surname>Chu</surname> <given-names>J.</given-names></name> <name><surname>Udupi</surname> <given-names>V.</given-names></name> <name><surname>Malaviya</surname> <given-names>S.</given-names></name> <name><surname>Carr</surname> <given-names>B. I.</given-names></name> <name><surname>Kar</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Jia</surname> <given-names>L.</given-names></name> <name><surname>Ji</surname> <given-names>X.</given-names></name> <name><surname>Keefer</surname> <given-names>L. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo</article-title>. <source>J. Med. Chem.</source> <volume>49</volume>, <fpage>4356</fpage>&#x02013;<lpage>4366</lpage>.<pub-id pub-id-type="doi">10.1021/jm060022h</pub-id><pub-id pub-id-type="pmid">16821795</pub-id></citation></ref>
<ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sherratt</surname> <given-names>P. J.</given-names></name> <name><surname>Pulford</surname> <given-names>D. J.</given-names></name> <name><surname>Harrison</surname> <given-names>D. J.</given-names></name> <name><surname>Green</surname> <given-names>T.</given-names></name> <name><surname>Hayes</surname> <given-names>J. D.</given-names></name></person-group> (<year>1997</year>). <article-title>Evidence that human class theta glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GSTT1 with that of classes alpha, mu and pi GST in human</article-title>. <source>Biochem. J.</source> <volume>326</volume>, <fpage>837</fpage>&#x02013;<lpage>846</lpage>.<pub-id pub-id-type="pmid">9307035</pub-id></citation></ref>
<ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>R.</given-names></name> <name><surname>Owen</surname> <given-names>L. A.</given-names></name> <name><surname>Trem</surname> <given-names>D. J.</given-names></name> <name><surname>Wong</surname> <given-names>J. S.</given-names></name> <name><surname>Whangbo</surname> <given-names>J. S.</given-names></name> <name><surname>Golub</surname> <given-names>T. R.</given-names></name> <name><surname>Lessnick</surname> <given-names>S. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing&#x02019;s sarcoma</article-title>. <source>Cancer Cell</source> <volume>9</volume>, <fpage>405</fpage>&#x02013;<lpage>416</lpage>.<pub-id pub-id-type="doi">10.1016/j.ccr.2006.04.004</pub-id><pub-id pub-id-type="pmid">16697960</pub-id></citation></ref>
<ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stanulla</surname> <given-names>M.</given-names></name> <name><surname>Schrappe</surname> <given-names>M.</given-names></name> <name><surname>Brechlin</surname> <given-names>A. M.</given-names></name> <name><surname>Zimmermann</surname> <given-names>M.</given-names></name> <name><surname>Welte</surname> <given-names>K.</given-names></name></person-group> (<year>2000</year>). <article-title>Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study</article-title>. <source>Blood</source> <volume>95</volume>, <fpage>1222</fpage>&#x02013;<lpage>1228</lpage>.<pub-id pub-id-type="pmid">10666194</pub-id></citation></ref>
<ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strange</surname> <given-names>R. C.</given-names></name> <name><surname>Howie</surname> <given-names>A. F.</given-names></name> <name><surname>Hume</surname> <given-names>R.</given-names></name> <name><surname>Matharoo</surname> <given-names>B.</given-names></name> <name><surname>Bell</surname> <given-names>J.</given-names></name> <name><surname>Hiley</surname> <given-names>C.</given-names></name> <name><surname>Jones</surname> <given-names>P.</given-names></name> <name><surname>Beckett</surname> <given-names>G. J.</given-names></name></person-group> (<year>1989</year>). <article-title>The development expression of alpha-, mu- and pi-class glutathione s-transferases in human liver</article-title>. <source>Biochem. Biophys. Acta</source> <volume>993</volume>, <fpage>186</fpage>&#x02013;<lpage>190</lpage>.</citation></ref>
<ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takanashi</surname> <given-names>M.</given-names></name> <name><surname>Morimoto</surname> <given-names>A.</given-names></name> <name><surname>Yagi</surname> <given-names>T.</given-names></name> <name><surname>Kuriyama</surname> <given-names>K.</given-names></name> <name><surname>Kano</surname> <given-names>G.</given-names></name> <name><surname>Imamura</surname> <given-names>T.</given-names></name> <name><surname>Hibi</surname> <given-names>S.</given-names></name> <name><surname>Todo</surname> <given-names>S.</given-names></name> <name><surname>Imashuku</surname> <given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia</article-title>. <source>Haematologica</source> <volume>88</volume>, <fpage>1238</fpage>&#x02013;<lpage>1244</lpage>.<pub-id pub-id-type="pmid">14607752</pub-id></citation></ref>
<ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>K. L.</given-names></name> <name><surname>Chelyanayagam</surname> <given-names>G.</given-names></name> <name><surname>Parker</surname> <given-names>M. W.</given-names></name> <name><surname>Board</surname> <given-names>P. G.</given-names></name></person-group> (<year>1996</year>). <article-title>Mutagenesis of the active site of the human Theta-class glutathione transferase GSTT2-2: catalysis with different substrates involves different residues</article-title>. <source>Biochem. J.</source> <volume>319</volume>, <fpage>315</fpage>&#x02013;<lpage>321</lpage>.<pub-id pub-id-type="pmid">8870684</pub-id></citation></ref>
<ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka-Kagawa</surname> <given-names>T.</given-names></name> <name><surname>Jinno</surname> <given-names>H.</given-names></name> <name><surname>Hasegawa</surname> <given-names>T.</given-names></name> <name><surname>Makino</surname> <given-names>Y.</given-names></name> <name><surname>Seko</surname> <given-names>Y.</given-names></name> <name><surname>Hanjoka</surname> <given-names>N.</given-names></name> <name><surname>Ando</surname> <given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Functional characterization of two variant human GSTO1-1s (Ala40Asp and Thr217Asn)</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>301</volume>, <fpage>516</fpage>&#x02013;<lpage>520</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-291X(02)03066-8</pub-id><pub-id pub-id-type="pmid">12565892</pub-id></citation></ref>
<ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tew</surname> <given-names>K. D.</given-names></name> <name><surname>Dutta</surname> <given-names>S.</given-names></name> <name><surname>Schultz</surname> <given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Inhibitors of glutathione S-transferases as therapeutic agents</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>26</volume>, <fpage>91</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="doi">10.1016/S0169-409X(97)00029-X</pub-id><pub-id pub-id-type="pmid">10837536</pub-id></citation></ref>
<ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tew</surname> <given-names>K. D.</given-names></name> <name><surname>Manevich</surname> <given-names>Y.</given-names></name> <name><surname>Grek</surname> <given-names>C.</given-names></name> <name><surname>Xiong</surname> <given-names>Y.</given-names></name> <name><surname>Uys</surname> <given-names>J.</given-names></name> <name><surname>Townsend</surname> <given-names>D. M.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of glutathione s-transferase P in signaling pathways and s-glutathionylation in cancer</article-title>. <source>Free Radic. Biol. Med.</source> <volume>51</volume>, <fpage>299</fpage>&#x02013;<lpage>313</lpage>.<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.04.013</pub-id><pub-id pub-id-type="pmid">21558000</pub-id></citation></ref>
<ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tew</surname> <given-names>K. D.</given-names></name> <name><surname>Monks</surname> <given-names>A.</given-names></name> <name><surname>Barone</surname> <given-names>L.</given-names></name> <name><surname>Rosser</surname> <given-names>D.</given-names></name> <name><surname>Akerman</surname> <given-names>G.</given-names></name> <name><surname>Montali</surname> <given-names>J. A.</given-names></name> <name><surname>Wheatley</surname> <given-names>J. B.</given-names></name> <name><surname>Schmidt</surname> <given-names>D. E.</given-names></name></person-group> (<year>1996</year>). <article-title>Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program</article-title>. <source>Mol. Pharmacol.</source> <volume>50</volume>, <fpage>149</fpage>&#x02013;<lpage>159</lpage>.<pub-id pub-id-type="pmid">8700107</pub-id></citation></ref>
<ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timofeeva</surname> <given-names>M.</given-names></name> <name><surname>Jager</surname> <given-names>B.</given-names></name> <name><surname>Rosenberger</surname> <given-names>A.</given-names></name> <name><surname>Sauter</surname> <given-names>W.</given-names></name> <name><surname>Wichmann</surname> <given-names>H. E.</given-names></name> <collab>KORA Study Group</collab> <name><surname>Bickeboller</surname> <given-names>H.</given-names></name> <name><surname>Risch</surname> <given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>A multiplex real-time PCR method for detection of GSTM1 and GSTT1 copy numbers</article-title>. <source>Clin. Biochem.</source> <volume>42</volume>, <fpage>500</fpage>&#x02013;<lpage>509</lpage>.<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2008.12.011</pub-id><pub-id pub-id-type="pmid">19161997</pub-id></citation></ref>
<ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tirado</surname> <given-names>O. M.</given-names></name> <name><surname>Mateo-Lozano</surname> <given-names>S.</given-names></name> <name><surname>Villar</surname> <given-names>J.</given-names></name> <name><surname>Dettin</surname> <given-names>L. E.</given-names></name> <name><surname>Llort</surname> <given-names>A.</given-names></name> <name><surname>Gallego</surname> <given-names>S.</given-names></name> <name><surname>Ban</surname> <given-names>J.</given-names></name> <name><surname>Kovar</surname> <given-names>H.</given-names></name> <name><surname>Notario</surname> <given-names>V.</given-names></name></person-group> (<year>2006</year>). <article-title>Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing&#x02019;s sarcoma cells</article-title>. <source>Cancer Res.</source> <volume>66</volume>, <fpage>9937</fpage>&#x02013;<lpage>9947</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-0927</pub-id><pub-id pub-id-type="pmid">17047056</pub-id></citation></ref>
<ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname> <given-names>Z.</given-names></name> <name><surname>Board</surname> <given-names>P. G.</given-names></name> <name><surname>Anders</surname> <given-names>M. W.</given-names></name></person-group> (<year>1998a</year>). <article-title>Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid</article-title>. <source>Biochem. J.</source> <volume>331</volume>, <fpage>371</fpage>&#x02013;<lpage>374</lpage>.</citation></ref>
<ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname> <given-names>Z.</given-names></name> <name><surname>Board</surname> <given-names>P. G.</given-names></name> <name><surname>Anders</surname> <given-names>M. W.</given-names></name></person-group> (<year>1998b</year>). <article-title>Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other &#x003B1;-haloacids</article-title>. <source>Chem. Res. Toxicol.</source> <volume>11</volume>, <fpage>1332</fpage>&#x02013;<lpage>1338</lpage>.<pub-id pub-id-type="doi">10.1021/tx980144f</pub-id></citation></ref>
<ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname> <given-names>D. M.</given-names></name> <name><surname>Tew</surname> <given-names>K. D.</given-names></name></person-group> (<year>2003</year>). <article-title>The role of glutathione-s-transferase in anti-cancer drug resistance</article-title>. <source>Oncogene</source> <volume>22</volume>, <fpage>7369</fpage>&#x02013;<lpage>7375</lpage>.<pub-id pub-id-type="doi">10.1038/sj.onc.1206940</pub-id><pub-id pub-id-type="pmid">14576844</pub-id></citation></ref>
<ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turc-Carel</surname> <given-names>C.</given-names></name> <name><surname>Aurias</surname> <given-names>A.</given-names></name> <name><surname>Mugneret</surname> <given-names>F.</given-names></name> <name><surname>Lizard</surname> <given-names>S.</given-names></name> <name><surname>Sidaner</surname> <given-names>I.</given-names></name> <name><surname>Volk</surname> <given-names>C.</given-names></name> <name><surname>Thiery</surname> <given-names>J. P.</given-names></name> <name><surname>Olschwang</surname> <given-names>S.</given-names></name> <name><surname>Philip</surname> <given-names>I.</given-names></name> <name><surname>Berger</surname> <given-names>M. P.</given-names></name> <name><surname>Philip</surname> <given-names>T.</given-names></name> <name><surname>Lenoir</surname> <given-names>G. M.</given-names></name> <name><surname>Mazabraud</surname> <given-names>A.</given-names></name></person-group> (<year>1988</year>). <article-title>Chromosomes in Ewing&#x02019;s sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12)</article-title>. <source>Cancer Genet. Cytogenet.</source> <volume>32</volume>, <fpage>229</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="doi">10.1016/0165-4608(88)90285-3</pub-id><pub-id pub-id-type="pmid">3163261</pub-id></citation></ref>
<ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turella</surname> <given-names>P.</given-names></name> <name><surname>Cerella</surname> <given-names>C.</given-names></name> <name><surname>Filomeni</surname> <given-names>G.</given-names></name> <name><surname>Bullo</surname> <given-names>A.</given-names></name> <name><surname>De Maria</surname> <given-names>F.</given-names></name> <name><surname>Ghibelli</surname> <given-names>L.</given-names></name> <name><surname>Ciriolo</surname> <given-names>M. R.</given-names></name> <name><surname>Cianfriglia</surname> <given-names>M.</given-names></name> <name><surname>Mattei</surname> <given-names>M.</given-names></name> <name><surname>Federici</surname> <given-names>G.</given-names></name> <name><surname>Ricci</surname> <given-names>G.</given-names></name> <name><surname>Caccuri</surname> <given-names>A. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Proapoptotic activity of new glutathione S-transferase inhibitors</article-title>. <source>Cancer Res.</source> <volume>65</volume>, <fpage>3751</fpage>&#x02013;<lpage>3761</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-3903</pub-id><pub-id pub-id-type="pmid">15867371</pub-id></citation></ref>
<ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turella</surname> <given-names>P.</given-names></name> <name><surname>Filomeni</surname> <given-names>G.</given-names></name> <name><surname>Dupuis</surname> <given-names>M. L.</given-names></name> <name><surname>Ciriolo</surname> <given-names>M. R.</given-names></name> <name><surname>Molinari</surname> <given-names>A.</given-names></name> <name><surname>De Maria</surname> <given-names>F.</given-names></name> <name><surname>Tombesi</surname> <given-names>M.</given-names></name> <name><surname>Cianfriglia</surname> <given-names>M.</given-names></name> <name><surname>Federici</surname> <given-names>G.</given-names></name> <name><surname>Ricci</surname> <given-names>G.</given-names></name> <name><surname>Caccuri</surname> <given-names>A. M.</given-names></name></person-group> (<year>2006</year>). <article-title>A strong glutathione s-transferase inhibitor overcomes the P-glycoprotein-mediated resistance in tumor cells: NBDHEX triggers a caspase-dependent apoptosis in MDR1-expressing leukemia cells</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume>, <fpage>23725</fpage>&#x02013;<lpage>23732</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M604372200</pub-id><pub-id pub-id-type="pmid">16769721</pub-id></citation></ref>
<ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wondrak</surname> <given-names>G. T.</given-names></name></person-group> (<year>2009</year>). <article-title>Redox-directed cancer therapeutics: molecular mechanisms and opportunities</article-title>. <source>Antioxid. Redox Signal.</source> <volume>11</volume>, <fpage>3013</fpage>&#x02013;<lpage>3069</lpage>.<pub-id pub-id-type="doi">10.1089/ars.2009.2541</pub-id><pub-id pub-id-type="pmid">19496700</pub-id></citation></ref>
<ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Y.</given-names></name> <name><surname>Fan</surname> <given-names>Y.</given-names></name> <name><surname>Xue</surname> <given-names>B.</given-names></name> <name><surname>Luo</surname> <given-names>L.</given-names></name> <name><surname>Shen</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Jiang</surname> <given-names>Y.</given-names></name> <name><surname>Yin</surname> <given-names>Z.</given-names></name></person-group> (<year>2006</year>). <article-title>Human glutathion s-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals</article-title>. <source>Oncogene</source> <volume>25</volume>, <fpage>5787</fpage>&#x02013;<lpage>5800</lpage>.<pub-id pub-id-type="doi">10.1038/sj.onc.1209191</pub-id><pub-id pub-id-type="pmid">16636664</pub-id></citation></ref>
<ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname> <given-names>S.</given-names></name> <name><surname>Howie</surname> <given-names>A. F.</given-names></name> <name><surname>Ketterer</surname> <given-names>B.</given-names></name> <name><surname>Taylor</surname> <given-names>J.</given-names></name> <name><surname>Hayes</surname> <given-names>J. D.</given-names></name> <name><surname>Beckett</surname> <given-names>G. J.</given-names></name> <name><surname>Wathen</surname> <given-names>C. G.</given-names></name> <name><surname>Wolf</surname> <given-names>C. R.</given-names></name> <name><surname>Spurr</surname> <given-names>N. K.</given-names></name></person-group> (<year>1991</year>). <article-title>Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility</article-title>. <source>Carcinogenesis</source> <volume>12</volume>, <fpage>1533</fpage>&#x02013;<lpage>1537</lpage>.<pub-id pub-id-type="doi">10.1093/carcin/12.9.1533</pub-id><pub-id pub-id-type="pmid">1680031</pub-id></citation></ref>
<ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zielinska</surname> <given-names>E.</given-names></name> <name><surname>Zubowska</surname> <given-names>M.</given-names></name> <name><surname>Bodalski</surname> <given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Polymorphism within the glutathione S-transferase P1 gene is associated with increased susceptibility to childhood malignant diseases</article-title>. <source>Pediatr. Blood Cancer</source> <volume>43</volume>, <fpage>552</fpage>&#x02013;<lpage>559</lpage>.<pub-id pub-id-type="doi">10.1002/pbc.20059</pub-id><pub-id pub-id-type="pmid">15382272</pub-id></citation></ref>
</ref-list>
</back>
</article>
